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Supervisor: Hirofumi Tanaka 
Recent evidence suggests that modifiable cardiovascular risk factors additionally play a 
causal role in the development of dementia and cognitive dysfunction.  Currently, no cure 
for dementia exists making identification of early relationships in dementia 
pathophysiology critical for the purpose of primary prevention or remediation. As 
approximately 70% of adults in the United States are clinically overweight, the aim of 
Study 1 was to determine the anthropometric measures most strongly associated with 
early white matter disease and cognitive function at midlife. In this cross-sectional 
investigation of 126 middle-aged adults, waist circumference, body fat percentage, and 
visceral adiposity all significantly predicted white matter hyperintensities, indicating that 
midlife abdominal obesity is associated with the early development of white mater 
disease. 
 Midlife visceral adiposity is also associated with increased arterial stiffening. The 
aim of Study 2 was to determine if subclinical carotid artery stiffening is associated with 
lower cerebral white matter integrity at midlife in a priori regions of interest susceptible 
to vascular and cognitive aging. This study employed diffusion tensor imaging to gauge 
cerebral white matter integrity. In a middle-aged cohort of 143 adults, we determined that 
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arterial stiffening was associated with reduced integrity of multiple white matter regions 
independent of age, sex, and waist circumference. Arterial stiffness indirectly affected 
processing speed. These data suggest that arterial stiffening may negatively affect CWMI 
prior to clinically overt cognitive decline. 
 Individuals with metabolic syndrome are at increased risk of arterial stiffening 
and dementia. The purpose of Study 3 was to determine the role of physical activity on 
mitigating the adverse influence of metabolic syndrome on arterial stiffness and cerebral 
white matter integrity. In this cross-sectional investigation of 66 middle-aged adults, 
individuals with MetS who were physically active demonstrated lower arterial stiffness 
and more favorable CWM integrity than their sedentary peers, indicating that PA may be 
effective in mitigating the adverse effects of MetS on the vasculature and brain at midlife. 
 Taken together, these findings indicate that cardiometabolic risk factors 
negatively affect the vasculature, cerebral white matter health, and cognitive function at 
middle-age.   
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CHAPTER 1: GENERAL INTRODUCTION 
 Dementia is defined as a major neurocognitive disorder due to its disruption of 
cognitive function and performance of activities of daily living (15).  Alzheimer’s disease 
and vascular dementia represent the two most common causes of dementia contributing 
to ~60-80% and ~10% of cases respectively.  The rise in incidence of AD in the United 
States is staggering as the 4.7 millions of people with AD is expected to nearly triple by 
the year 2050 (15). With no curative treatment known for dementia, identification of 
early modifiable biomarkers is critical, especially given that AD pathophysiology takes 
years, if not decades, to progress (175). Although the causal mechanisms of AD are 
complex and multiple, vascular dysregulation has recently been identified as a key 
initiating event (143). 
 Because the brain’s ability to store energy is limited, it is highly dependent on the 
cardiac output to receive energy substrate. Despite weighing just 2% of body weight, the 
brain receives 11% of the cardiac output and consumes 20% of the total oxygen of the 
body at rest (52). The tight delivery of cerebral blood flow is reliant on the perfusing 
vasculature that becomes vulnerable to malfunction with exposure to cardiovascular risk 
factors. In brief, cardiovascular risk factors that include obesity, hypertension, 
dyslipidemia, dysglycemia, and smoking contribute to arteriosclerosis and begin a 
cascade of events that results in breakdown of the blood brain barrier (BBB) and cerebral 
hypoperfusion (65, 153). The consequences of hypoperfusion are significant, leading to 
white matter injury, buildup of amyloid-β, and susceptibility to dementia (342). 
Mitigating the adverse effects that cardiovascular risk factors have on the vasculature 
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may prove valuable for maintaining cerebral autoregulation and healthy white matter 
while prolonging normal cognition.  
 Alterations of cerebral white matter are associated with vascular risk factors and 
ischemia and are considered an early pathological feature of dementia (40, 69, 175). 
Sensitive measures of white matter health can be assessed with magnetic resonance 
imaging (MRI). The two most common methods are capturing T2-weighted images to 
determine white matter hyperintensities (WMH), and performing diffusion tensor 
imaging (DTI), a sequence measuring in vivo water diffusion of white matter tracts 
reflective of structural integrity. Observing their associations in relation to cardiovascular 
risk factors, vascular function, and cognitive function at early stages of disease progress 
can be informative for identifying modifiable treatment targets for clinicians. 
 
Purpose and Hypothesis 
In recent years there has been considerable growth in the study of cardiovascular health 
in relation to brain structure and cognitive function. However, the relations of vascular 
dysfunction with early pathological alterations ultimately contributing to dementia, 
otherwise termed the vascular hypothesis, remain understudied at midlife (143). 
Therefore, the general and overall goal of this dissertation study is to further understand 
modifiable cardiovascular targets related to early neuroimaging biomarkers of dementia 
and cognitive dysfunction. This broad goal was addressed in three specific aims, each 
focused on different levels of the vascular hypothesis of dementia. Whole-body and 
abdominal adiposity, arterial stiffness, and physical activity was  carefully analyzed in 
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relation to cerebral white matter health and cognitive function. The role of physical 
activity as a basic lifestyle modification to improve vascular health and ostensibly brain 
structure and function will be determined. 
STUDY #1:  
 The purpose of Study #1 was to determine the strength of associations of body 
mass index (BMI), waist-to-hip ratio (WHR), waist circumference (WC), percent body 
fat (BF), and visceral adipose tissue (VAT) with white matter hyperintensity (WMH) and 
cognitive function at midlife. We hypothesized that dual-energy x-ray absorptiometry 
(DXA)-generated adiposity measures of BF and VAT would be more sensitive in 
predicting WMH and cognitive function at midlife than traditional anthropometric body 
composition measurements. 
STUDY #2:  
 The purpose of Study #2 was to determine whether carotid artery stiffening 
impacts cerebral white matter microstructure at midlife. Secondly, we aimed to determine 
what white matter regions vascular stiffening would most likely hinder.  We 
hypothesized that carotid artery stiffening would be negatively associated with a priori 
cerebral white matter regions that are closely related to executive function. 
STUDY #3:  
 The purpose of Study #3 was to determine whether individuals with metabolic 
syndrome (MetS) who habitually perform physical activity demonstrate lower arterial 
stiffness and more favorable cerebral white matter integrity than their sedentary peers.  
Our working hypothesis was that MetS patients who habitually exercise do not 
demonstrate arterial stiffening and reduced cerebral white matter integrity.  
  4 
CHAPTER 2: VISCERAL ADIPOSITY PREDICTS SUBCLINICAL 
WHITE MATTER HYPERINTENSITIES IN MIDDLE-AGED 
ADULTS1 
Abstract 
Objective: Growing prevalence of neuropathology and cognitive impairment are 
emerging consequences of the obesity epidemic. Adiposity indices used in examining the 
relationships between obesity, neuropathology, and cognition vary substantially in the 
literature leading to incongruent findings. Our aim was to determine the anthropometric 
measures most strongly associated with early white matter disease and cognitive function 
at midlife. Method: Multiple adiposity indices were measured in 126 adults aged 40-62 
who also completed a magnetic resonance imaging (MRI) scan to quantify white matter 
disease and a cognitive test battery. Anthropometric indices of obesity were compared to 
image-based estimates of visceral adipose tissue with dual-energy x-ray absorptiometry 
(DEXA) as predictors of current white matter disease and cognitive function. We also 
explored sex as a potential moderator of these relationships. Results: Waist 
circumference (WC) was most strongly correlated with DEXA estimates of visceral 
adipose tissue (r=0.871, p<0.001). Increasing WC (β=0.231, p=0.034), percent body fat 
(β=0.230, p=0.045), and VAT (β=0.247, p=0.027) significantly predicted subclinical 
white matter hyperintensities in the absence of cognitive impairment after accounting for 
age, sex, years of education, and cardiovascular risk factors. Sex was not a significant 
1Pasha EP, Birdsill A, Parker P, Elmenshawy A, Tanaka H, Haley AP. Visceral 
adiposity predicts subclinical white matter hyperintensities in middle-aged adults. Obes  
Res Clin Pract. 2016. 
 
Pasha EP designed the investigation, acquired data, performed statistics and wrote the 
manuscript.  
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moderator of any of the observed relationships. Conclusions: Of the anthropometric 
indices used in this study, WC, BF, and VAT successfully predicted subclinical white m 
atter disease in cognitively normal adults at midlife. Increasing VAT may independently 
insidiously affect cerebral white matter prior to detectable cognitive changes, 
necessitating early intervention.  
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Introduction 
Obesity in the United States has become a pressing public health issue with 68.5% 
of adults over the age of 20 fulfilling criteria for overweight or obesity, and 34.9% 
classified as having obesity in 2011-2012 (211). Despite recent public health measures to 
curb the increase in the number of individuals with obesity, a recent study suggested 
obesity rates could rise until a steady state proportion of 42% by 2050 (131). An 
emerging consequence of having obesity is neurologic disease and cognitive deficit, 
independent of other cardiovascular comorbidities (267). Because the relationships 
between obesity measures and cognitive function and brain structure appear non-linear 
due to age related changes in body composition, determining the most robust adiposity 
measurements during midlife for estimating neurological vulnerability and cognitive 
function is critical (112). 
Past work has suggested waist circumference (WC) as an ideal anthropometric 
measure of visceral adipose tissue (VAT) when investigating obesity in relation to 
cardiovascular comorbidities such as hypercholesterolemia and insulin resistance (230). 
VAT serves as an endocrine organ that secretes adipocytokines such as interleukins that 
can exacerbate inflammation and impair vascular function more than subcutaneous 
adipose tissue alone (17). VAT is a likely culprit behind observations linking higher body 
mass index (BMI) at midlife to increased risk of dementia in older age (114). 
Consequently, VAT could act to limit cerebral perfusion that can culminate in 
neuropathology and cognitive dysfunction (232) (62). In our own work with middle-aged 
adults, VAT has been linked to altered cortical thickness (157). Thus, anthropometric 
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measurements could be valuable indicators of early neurocognitive alterations if they 
accurately reflect visceral adipose tissue.  
Currently, adiposity measures remain substantially varied in the literature in 
prospective studies examining obesity in relation to neurologic disease and cognitive 
decline with great reliance on BMI.  However, BMI lacks specificity to appropriately 
quantify the deleterious VAT typically linked to adverse health outcomes (230). One 
study examined differences in the associations between obesity indices and cognitive 
function cross-sectionally and longitudinally at middle age (109). This group determined 
BMI and abdominal obesity measures including WC and waist-to-hip ratio (WHR) were 
all similarly associated with cognitive function tests in the global, executive and memory 
domains. (109). Nonetheless, these simple anthropometric indices have rarely been 
compared with an image-based estimate of VAT such as dual-energy x-ray 
absorptiometry (DEXA) in their associations to both neuropathology and cognitive 
function. Such a comparison can further elucidate the relative strength of relationships of 
obesity indices to neuropathology and cognitive function in younger adults.  
A well-founded neuropathological marker seen in dementia and Alzheimer’s 
disease is the volume of white matter hyperintensities (WMH) (40). WMH are usually 
denoted by areas of high intensity on T2 weighted magnetic-resonance imaging (MRI) 
scans that are believed to be the result of chronic hypoperfusion and correlated with 
myelin and axonal loss (41, 299). Prior studies have observed associations between body 
composition and WMH in the elderly (146), but reports of said relationship at midlife are 
scarce. One study reported no significant associations between anthropometric measures 
and computed tomography (CT)-based measurements of VAT with WMH volume three 
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years later in older middle age (mean age at CT = 64; mean age at MRI = 67 years) (68). 
This study also did not investigate the relationships between anthropometric measures 
and cognitive function. The purpose of our study was to determine the strength of 
associations of concurrently obtained BMI, WHR, WC, percent body fat (BF), and VAT 
with WMH and cognitive function in a younger middle-aged population (ages 40-60 
years). We hypothesized that DEXA generated adiposity measures of BF and VAT would 
be more sensitive in predicting WMH and cognitive function at midlife than traditional 
anthropometric body composition measurements.  
Methods 
Participants 
Recruitment through local newspaper and online advertisements generated a multi-racial 
sample of 126 community dwelling men and women aged 40-62 years representative of 
the Austin, Texas area. To be admitted to the study, participants had to have no pre-
existing cardiovascular disease (e.g., coronary artery disease, angina pectoris, myocardial 
infarction, heart failure, and cardiac surgery), overt neurological disease (e.g., stroke, 
Parkinson’s disease, and clinically significant traumatic brain injury), or 
contraindications to MRI assessed through self-report on a health history questionnaire. 
Additionally, participants were non-depressed and cognitively normal as determined by 
scoring <29 on the Beck Depression Inventory-II and >84 on the Wechsler Abbreviated 
scale of Intelligence-II (WASI-II) Full Scale Intelligence Quotient (FSIQ).  The local 
institutional review board approved the study and all participants gave informed consent. 
Health Assessment 
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Following an overnight fast of at least 8 hours, blood was collected from the antecubital 
vein via venipucture. Glucose and total cholesterol levels were determined using standard 
enzymatic technique. Brachial systolic and diastolic blood pressure was assessed in the 
supine position after a 15-min period of rest (VP-2000; Omron Healthcare, Bannockburn, 
IL). Participants completed a detailed health history questionnaire outlining medication 
use and current physical activity behavior.  
Obesity Indices 
Height and weight were measured with a stadiometer and digital scale respectively for 
the calculation of BMI as kg/m2. WC was measured with a measuring tape at the top of 
the iliac crest as measurement at the level of the navel may underestimate WC (60). The 
measuring tape was level to the floor and softly tightened without compressing tissues in 
accordance with National Heart, Lung and Blood Institute clinical guidelines (1). Hip 
circumference (HC) was measured in an identical method to WC but at the level of the 
greatest protrusion of the hips. Both WC and HC were recorded in centimeters to the 
nearest millimeter. WHR was then calculated as WC/HC. Estimates of BF and VAT were 
ascertained non-invasively with a lunar DXA DPX (General Electric Medical Systems, 
Fairfield, CT). Although DEXA is typically used to measure bone mineral density, it has 
been validated for body fat and visceral fat mass estimation with results similar to 
computed tomography (156, 326). BF was calculated as estimated total fat mass 
expressed as a percentage of whole body mass. To obtain an estimation of VAT, a region 
of interest with a caudal limit placed atop the iliac crest with its height set to 20% of the 
distance from the caudal limit to the base of the skull is automatically defined. Within 
this region, subcutaneous fat estimates are subtracted from total fat estimates to yield a 
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VAT estimate. During a separate visit, participants underwent a comprehensive cognitive 
function assessment and a MRI scan.  
Clinical Assessment 
The Beck Depression Inventory-II (BDI-II) was first used as a screening measure for 
depression, followed by a cognitive function battery that has been described in previous 
work (99). In short, administered tests included the Mini Mental State Examination 
(MMSE) to assess overall mental health status. Additionally, the Trail Making Test A 
and B, Wechsler Adult Intelligence Scale III (WAIS-III) Digit Span subtest, and Stroop 
interference subtest were used to characterize executive function. The California verbal 
learning test (CVLT)-II short delay free recall, long delay free recall, and recognition 
discriminability tasks characterized memory function. Domain specific Z-scores were 
created with timed tasks for directional congruity. Z-scores from tasks within each 
domain were averaged to create the executive function and memory domain score. 
Altogether, this procedure constituted a one hour testing battery.  Each of the chosen 
clinical instruments has established reliability and validity. Trained research assistants 
administered cognitive testing in the morning, irrespective of menstrual cycle for female 
participants. The same assistants performed all scoring, enabling standardization of 
administration.  
MRI Acquisition and Analysis 
MRI data was acquired on a 3T Siemens Skyra MRI scanner and included a T1 image of 
the entire brain acquired in the sagittal plane using a high-resolution ultrafast Gradient 
Echo 3D (MPRAGE) sequence (256×256 matrix, flip angle=7°, field of view 
(FOV)=24×24 cm2, 1 mm slice thickness, 0 gap). A T2 image was acquired using a fluid-
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attenuated inversion-recovery (FLAIR) sequence (axial plane, TE=75 ms, TR=9500 ms, 
FOV=24x24 cm2, 42 slices, 3 mm slice thickness, 0.3 gap).  
 WMH volume was quantified by Lesion Segmentation Tool version 1.2.3 
(http://www.applied-statistics.de/lst.html), an automated algorithm implemented in SPM8 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). A detailed description of The Lesion 
Segmentation Tool algorithm can be found elsewhere (249). Briefly, voxels were 
assigned to tissue probability maps and given a probability of being a white matter lesion 
based on spatial and intensity probabilities from T1 images and hyperintensity outliers on 
T2 FLAIR images. A conservative lesion belief map containing gray and white matter 
voxels was created and an initial threshold of 0.30 was applied to create lesion seeds. A 
growth algorithm then grew these seeds toward a liberal lesion belief map containing 
gray, white, and CSF lesion belief maps. A final threshold of 0.99 was applied to the 
resulting lesion belief map to remove any voxels with a lower probability of being a 
lesion. The resulting total volume of WMH was divided by intracranial volume, obtained 
through Freesurfer (https://surfer.nmr.mgh.harvard.edu/), and multiplied by 100 to give a 
white matter hyperintensity ratio (WMHr) in units of percentage of intracranial volume. 
Statistical analyses. Sample means and standard deviations for physiological and 
cognitive variables were assessed with descriptive statistics. All descriptive variables 
passed Shapiro-Wilk tests for normality except for VAT (Shapiro-Wilk Statistic=0.911, 
p<0.001) and WMHr (Shapiro-Wilk Statistic=0.520, p<0.001). Consequently, a square 
root transformation was performed on VAT and a natural log transformation was utilized 
on WMHr resulting in normality of both variables. To avoid multiple comparisons in the 
cognitive realm, domain scores for executive function and memory were created and used 
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as primary outcome variables. An average of the Trails A, Trails B, WAIS-III Digit Span, 
and Stroop interference sample based z-scores constructed the executive function domain 
score. The z scores for timed tests were inverted, so that a higher score indicates better 
performance, consistent with the scoring of the tests where total correct responses was the 
outcome variable of interest.  An average of the sample-based z-scores for CVLT-II short 
delay free recall, long delay free recall and recognition discriminability tests formed the 
domain score for memory.  
To evaluate the relation between body composition measures, WMH, and 
cognitive function, two linear regression models were constructed for each outcome 
variable (WMH, executive domain score, and memory domain score). The first model 
statistically adjusted for age, sex, and education. The second model adjusted for age, sex, 
education, systolic blood pressure, total cholesterol and fasting glucose. Covariates were 
selected based on their existing relations to body composition and WMH within the 
literature (39, 147).  Because of known sex differences in the distribution of adiposity, 
sex differences in obesity indices, white matter disease, and domain cognitive function 
were compared with independent samples t-tests (155). Sex was also investigated as a 
moderating variable between body composition measures, white matter disease, and 
cognitive function using non-parametric bootstrapping (the MODPROBE macro for 
SPSS) (126). An alpha level of 0.05 was used as the criterion for statistical significance 
in parametric analyses; 95% confidence interval (CI) not containing zero was used as the 
criterion for statistical significance in the non-parametric analyses. Statistical analyses 
were performed with SPSS version 22.0 (IBM SPSS Inc, Chicago, IL).  
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Results 
Descriptive Statistics. Of the 126 participants recruited for this study, 57 (45.2%) 
were male and 69 (54.8%) were female. The sample was highly educated (16.3 ± 2.3 
years) and ethnically diverse with 74 (58.7%) participants identifying as Caucasian, 8 
(6.3%) as African American, 26 (20.6%) as Hispanic, 5 (4.0%) as Asian, and 10 (7.9%) 
as other or did not respond. Participants were middle aged (49.1 ± 6.6 years) and 
displayed overweight (28.5 ± 6.5 kg/m2) BMI, but presented with healthy blood pressure, 
fasting lipids, and glucose on average. Remaining participant descriptive characteristics 
are presented in Table 2.1. WMHr was 0.17% ± 0.26 reflecting a pathologically 
subclinical subject population (231).  
Obesity Indices. All anthropometric obesity indices as well as BF were 
significantly correlated with VAT. WC (r=0.871, p<0.001), had the strongest relation to 
VAT followed by BMI (r=0.693, p<0.001), WHR (r=0.574, p<0.001) and BF (r=0.473, 
p<0.001). Other significant relations existed between obesity indices and are enumerated 
in Table 2.2. T-tests revealed significant differences between sexes for all body 
composition measures (p<0.05) except BMI as shown in Table 2.3. 
Body Composition Indices and White Matter Hyperintensities. Correlation results 
of linear regression models of body composition indices and WMH are displayed in 
Table 2.4. In the first model, adjusting for age, sex and years of education, WC (β=0.184, 
p=0.049) and VAT (β=0.218, p=0.021) significantly predicted WMH whereas BMI 
(β=0.100, p=0.274), WHR (β=0.048, p=0.646), and BF (β=0.195, p=0.054) did not. The 
second model included clinically pertinent parameters of systolic blood pressure, total 
cholesterol and glucose that potentially influence white matter disease. After accounting 
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for these contributions, WC (β=0.231, p=0.034), BF (β=0.230, p=0.045), and VAT 
(β=0.247, p=0.027) remained as significant predictors of WMH. BMI (β=0.129, p=0.198) 
and WHR (β=0.034, p=0.767) remained statistically insignificant. All model residuals 
were normally distributed (Shapiro-Wilk, p>0.05). Significant relations from this final 
model are displayed in Figure 2.1a-c. Sex was not a significant moderator of the 
relationship between obesity indices and WMH with 95% CIs straddling zero for all 
predictors. 
Obesity Indices and Cognitive Function. Raw scores for individual cognitive 
function assessments are outlined in Table 2.5. Linear regression models relating obesity 
measures to executive function and memory domain scores are summarized in Table 2.6. 
Again, the first model accounted for age, sex, and years of education, with the second 
adding systolic blood pressure, total cholesterol and fasting glucose. Although most of 
these models were statistically significant, none of the obesity measures significantly 
contributed to any model (p>0.05). In these models, residuals were normally distributed 
when predicting executive function domain scores (Shapiro-Wilk, p>0.05). However, 
models predicting memory domain scores were not normally distributed (Shapiro-Wilk, 
p<0.05) despite transformations. Nonetheless, in memory domain models, the residual 
skewness range was -0.558 to -0.447 with a standard error of 0.225. Sex differences were 
observed in domain z-scores for memory (p=0.001) but not executive function (p>0.05). 
However, sex did not significantly moderate the relationships between obesity indices 
and cognitive function in either domain, as 95% CIs for the executive and memory 
domains straddled zero in both models.  
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Discussion 
The principal findings from the present study are as follows. Congruent with our 
hypothesis, estimated VAT consistently related to WMH. Of the anthropometric obesity 
measures typically employed to evaluate the associations of obesity, neuropathology and 
cognition, only WC was as robust as VAT in predicting subclinical white matter disease. 
WC also predicted early WMH independent of the influence of other cardiovascular risk 
factors. This finding indicates WC as a proxy measure of VAT is sensitive to early white 
matter vulnerability and possibly independently contributes to WMH. None of the 
observed adiposity measures significantly related to executive function or memory 
domain scores. WC appears to be the closest anthropometric reflection of abdominal fat, 
having the strongest correlation with VAT and corroborates visceral fat as a culprit 
behind obesity related WMH. WC was sensitive enough to predict early WMH prior to 
the precipitation of cognitive abnormalities middle-aged subjects with low WMH 
volume. This study supports the use of WC as a more robust measure of early white 
matter vulnerability at midlife than the oft-used BMI and WHR. WC is also a safe, 
inexpensive alternative to DEXA. Lastly, the observed relationships were similar in both 
men and women.  
Our findings are largely consistent with previous investigations relating obesity to 
neuropathology and cognitive function. Our group and others have demonstrated that 
many of these body composition indices are individually correlated with neuropathology, 
but investigations of obesity and WMH at middle age are few. In a sample of community 
dwelling Latinos with mean age of 70 years, 1-SD increase in WHR corresponded to a 
27% increase in WMH after accounting for sex, cholesterol, blood pressure, and other 
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covariates (146). Similarly, a prospective study of Swedish women determined a 1 kg/m2 
increase in BMI at age 70 doubled the risk of obtaining WMH later in life (116). In the 
present study, only WC, BF, and VAT predicted WMH while BMI and WHR did not. 
This finding leads to the possibility that proxy measures of VAT are more sensitive 
measures for detecting associations between obesity and WMH.  
In contrast to our results, a previous investigation observed no significant 
associations between BMI, WC, WHR, and computed tomography-based estimates of 
subcutaneous adipose tissue and VAT with WMH (68). In this study, statistical 
adjustments were made for age, sex, systolic blood pressure, smoking, diabetes mellitus, 
history of cardiovascular disease, physical activity, and BMI to their models and still no 
relation was found in their cohort with mean age 64 years for the CT evaluation and 67 
years for the MRI valuation. While both methodological (e.g., CT vs. DEXA estimates of 
VAT; 1.5T vs. 3T MRI, consecutive vs. concurrent measurements of VAT and WMH) 
and study population differences (older vs. younger adults; lower vs. higher average WC) 
could have contributed to these result discrepancies, one cannot discount the possibility 
of a complex, non-linear relationship between adiposity and neuropathology throughout 
the lifespan. 
Contrary to our hypothesis, we did not find any significant relationships between 
obesity measures and cognitive function domain z-scores. Our sample was young and 
highly educated, which may have provided these individuals greater cognitive reserve 
and rendered them more tolerant to the adverse effects of obesity related cognitive 
decline (279). The subject population also presented with minimal white matter disease 
volume. A study examining leuokaraiosis and phenotypic expression of dementia 
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suggested working memory performance was negatively affected when it involved at 
least 3% of the white matter (231). The amount of white matter present in the subject 
population of the current study was well under this threshold suggesting subjects have yet 
to accumulate sufficient disease to alter cognitive function. What is striking is that WC, 
BF, and VAT were related to seemingly trivial amounts of white matter disease that if left 
unidentified could silently accumulate and eventually precipitate in cognitive impairment.  
Prior evidence has established an association between obesity and impaired cognitive 
function. For example, our group showed that higher WC corresponded to a worse 
working memory related brain hemodynamic response in middle-aged adults.  This 
impairment corresponded with poorer working memory task performance (99). We also 
demonstrated that DEXA measured VAT can alter cortical thickness in midlife (157). 
Further evidence entails a study where men and women with elevated WC scored lower 
on the Grooved Pegboard Test and Stroop test (316). A separate study using BMI showed 
men and women with overweight or obesity performed worse on executive function tests 
(111). In a similar investigation of older women, individuals with obesity determined by 
BMI performed more poorly on executive function tasks compared to normal weight 
individuals and this decrement was associated with reduced gray matter volume in the 
orbitofrontal cortex (317).  
There are many mechanisms potentially responsible for visceral adipose tissue 
inducing white matter disease and subsequent cognitive dysfunction. One major 
pathophysiological antecedent to the occurrence of white matter hyperintensities is 
chronic ischemia (106). Cardiovascular risk factors such as hypertension and 
dyslipidemia are often comorbid with obesity and at subclinical levels can negatively 
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affect cerebral perfusion (65). These risk factors may reduce cerebral perfusion through 
damaging the vascular endothelium resulting in impaired cerebral vasodilatory capacity 
(162). Adipose tissue is considered the largest endocrine organ in the body and secretes 
deleterious adipocytokines including interleukin-1, interleukin 6, tumor necrosis factor, 
leptin, and adiponectin, among others (232). It is well established that these 
adipocytokines exacerbate inflammation that disrupt the function of the vascular 
endothelium (11). Endothelial function aids in maintaining a sound blood-brain barrier 
and protecting small cerebral vessels from pulsatility and blocking toxic metabolites from 
entering the brain (30). Making matters worse, these adipocytokines can cross the blood-
brain barrier and affect the central nervous system (48, 322). Cross-sectional studies have 
shown proinflammatory cytokines are elevated in individuals with obesity, and play a 
role in dementia related neurodegeneration (105, 265). Further, in a cross-sectional study 
observing the role of inflammation and cognition in an elderly sample, increased IL-6 and 
C reactive protein correlated to increased cognitive decline (330). Although these 
outcomes may be distal to the population observed in the present study, the cumulative 
effects of adiposity at midlife, if untreated, may eventually surface as neuropathology and 
cognitive impairment through an inflammatory mechanism.  
Despite accomplishing the goal of our investigation, the present study is not 
without limitations. While there were many significant relations between body 
composition indices and WMH, the cross-sectional nature of this study means a causal 
link between obesity and WMH cannot be established. Other physiological markers and 
social factors may influence having obesity, neuropathology, and cognitive function 
independently or synergistically that we did not consider in this analysis. The role of pro-
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inflammatory cytokines that are typically elevated in individuals with overweight and 
obesity, and related to neuropathology, was not taken into account (322). Environmental 
factors such as socioeconomic status and social network strength, which may help stave 
off neuropathology and maintain cognitive function, were also not considered in this 
study (90, 96). While we did not consider these other factors in our analyses, their role in 
influencing the relations of obesity, neuropathology, and cognitive function should be 
considered in future work. Another potential limitation we encountered was a highly 
educated sample. Having a highly educated sample could ostensibly mask significant 
associations between neuropathology and current cognitive function through increased 
cognitive reserve. Finally, statistical adjustments for multiple comparisons were not 
employed. 
This study greatly benefited from the characteristics of the observed sample. The 
sample was racially diverse, and included an equal number of men and women, 
permitting for generalizability of our findings. Importantly, participants were relatively 
young, without major comorbidities, and had minimal white matter disease, emphasizing 
the utility of WC and DEXA body composition measures as early markers of white 
matter disease preceding deterioration of cognitive function.  This study also benefited by 
being one of the first to compare traditional and imaging body composition indices in 
their predictive value of early white matter disease and cognitive function. 
Conclusions 
In summary, after contrasting popular anthropometric obesity indices to image-
based estimates of visceral adiposity, only WC was as successful in predicting obesity 
related subclinical white matter disease at midlife as BF and VAT.  WC had the strongest 
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correlation with VAT. These results are congruent with and buttress literature that 
identifies WC as the ideal anthropometric measure when studying body composition in 
relation to neurocognitive vulnerability. This finding held true even after statistical 
adjustment for cardiovascular influences on WMH, suggesting increasing visceral 
adiposity independently negatively affects cerebral white matter at midlife prior to 
disruptions of cognitive function. While these findings need further replication and 
validation in large cross-sectional and prospective studies at midlife, we assert that future 
investigations relating obesity to brain structure and function should employ WC rather 
than BMI or WHR.  
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Table 2.1. Selected participant characteristics 
 
  Variable Mean ± SD 
Descriptive Male/Female 57/69 
 
Age, y 49.1 ± 6.7 
 
Caucasian, n (%) 74 (58.7) 
 
African American, n (%) 8 (6.3) 
 
Hispanic, n (%) 26 (20.6) 
 
Asian, n (%) 5 (4.0) 
 
Other, n (%) 8 (6.3) 
 
Did not respond, n (%) 2 (1.6) 
 
Education, y 16.3 ± 2.3 
 
Systolic Blood Pressure, mmHg 120 ± 12 
 
Diastolic Blood Pressure, mmHg 72 ± 9 
 
Total Cholesterol, mg/dL 199 ± 37 
 
High Density Lipoprotein, mg/dL 52 ± 16 
 
Low Density Lipoproteins, mg/dL 125 ± 33 
 
Triglycerides, mg/dL 112 ± 58 
 
Glucose, mg/dL 99 ± 29 
 
Body Mass Index, kg/m2 28 ± 7 
 
Waist Circumference, cm 94.8 ± 15.4 
 
Waist to Hip Ratio 0.89 ± 0.10 
 
Body Fat, % 34.1 ± 10.9 
 
Visceral Adipose, g 1121 ± 883 
 
White Matter Hyperintensity, % 0.17 ± 0.26 
Physical Activity  Moderate to Vigorous Exercise, hours/week 2.1 ± 6.5 
 
Moderate to Vigorous Exercise, bouts/week 3.7 ± 3.0 
 
Sitting, hours/day 8.3 ± 4.0 
Medications Anti-Hypertensive Medication, n (%) 21 (16.7) 
 
Lipid Lowering, n (%) 14 (11.1) 
 
Anti-Diabetic Medication, n (%) 5 (4) 
 
Hormone Replacement Therapy, n (%) 8 (6.3) 
 
Birth Control, n (%) 3 (2.4) 
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Table 2.2. Pearson's correlation coefficients between adiposity indices 
Index BMI WHR WC BF VAT 
BMI 1 .324** .850** .630** .693** 
WHR - 1 .643** .061 .574** 
WC - - 1 .560** .871** 
BF - - - 1 .473** 
VAT - - - - 1 
VAT, square root visceral adipose tissue; WC, waist circumference; BMI, body 
mass index; WHR, waist to hip ratio; BF, body fat percent 
**p< 0.01 
      
 
Table 2.3. Cognitive function assessment raw scores 
Measure Mean ± SD 
Global Cognition 
Mini Mental State Exam 28.7 ± 1.4 
 WASI-II 
 
FSIQ-2 Subtests 114.1 ± 12.5 
BDI-II 6.6 ± 5.3 
  Memory 
  CVLT-II 
Short delay free recall 11.0 ± 3.1 
Long delay free recall 11.6 ± 2.7 
Recognition discriminability 3.0 ± 0.7 
  Executive Function 
Trail making test A, s 29.1 ± 9.8 
Trail making test B, s 65.0 ± 29.1 
WAIS-III digit span subtest, total 20.3 ± 4.2 
Stroop interference 41.7 ± 10.6 
WASI-II, Wechsler Abbreviated scale of Intelligence II; 
CVLT-II, California Verbal Learning Test II; WAIS-III, 
Wechsler Adult Intelligence Scale III 
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Table 2.4. Linear regression models depicting the association between body composition 
indices and white matter hyperintensities 
  Predictor Model p β S.E. Predictor p 
Model 1 BMI 0.045* 0.100 0.014 0.274 
 
WHR 0.072 0.048 1.058 0.646 
 
WC 0.015* 0.184 0.006 0.049* 
 
BF 0.015* 0.195 0.009 0.054 
 
VAT 0.008* 0.218 0.007 0.021* 
      Model 2 BMI 0.109 0.129 0.016 0.198 
 
WHR 0.214 0.034 1.130 0.767 
 
WC 0.050* 0.231 0.007 0.034* 
 
BF 0.048* 0.230 0.010 0.045* 
  VAT 0.035* 0.247 0.008 0.027* 
BMI, body mass index; WHR, waist to hip ratio; WC, waist circumference; BF, 
body fat percent; VAT, square root visceral adipose tissue; SE, standard error 
*p<0.05 
Model 1: Age, sex, years of education controlled 
Model 2: Age, sex, years of education, blood pressure, total cholesterol, glucose 
controlled 
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Table 2.5. Linear regression models depicting the association between body composition 
indices and cognitive domain scores 
 
Domain Predictor Model p β S.E. Sig. 
Model 1 Executive  BMI 0.119 -0.062 0.009 0.500 
 
Function WHR 0.109 -0.087 0.673 0.406 
  
WC 0.110 -0.078 0.004 0.412 
  
BF 0.099 -0.099 0.006 0.338 
  
VAT 0.137 -0.030 0.004 0.754 
       
 
Memory BMI 0.001** 0.013 0.011 0.878 
  
WHR 0.001** -0.103 0.850 0.292 
  
WC 0.001** -0.054 0.005 0.545 
  
BF 0.001** 0.025 0.007 0.800 
    VAT 0.001** -0.022 0.006 0.807 
Model 2 Executive  BMI 0.016* 0.017 0.010 0.863 
 
Function WHR 0.015* 0.024 0.710 0.824 
  
WC 0.014* 0.050 0.004 0.643 
  
BF 0.016* 0.000 0.006 0.997 
  
VAT 0.001** 0.138 0.005 0.211 
       
 
Memory BMI 0.001** 0.013 0.013 0.891 
  
WHR 0.001** -0.118 0.926 0.271 
  
WC 0.001** -0.056 0.006 0.588 
  
BF 0.480 0.078 0.008 0.480 
    VAT 0.001** 0.013 0.007 0.903 
BMI, body mass index; WHR, waist to hip ratio; WC, waist circumference; BF, 
body fat percent; VAT, square root visceral adipose tissue; SE, standard error 
*p<0.05 
**p<0.01 
Model 1: Age, sex, years of education controlled 
Model 2: Age, sex, years of education, blood pressure, total cholesterol, glucose 
controlled 
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Figure 2.1a-c. Linear regression plots depicting the relationship of (a) waist 
circumference (b) body fat percentage (c) visceral adipose tissue and white matter 
hyperintensities.  
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CHAPTER 3: INDIRECT IMPACT OF MIDLIFE ARTERY 
STIFFENING ON COGNITION THROUGH CERBRAL WHITE 
MATTER MICROSTRUCTURE INTEGRITY 
Abstract 
Objective: In addition to being an independent predictor of cardiovascular events, aortic 
stiffness is related to cognitive dysfunction, white matter disease, and dementia in elderly 
individuals. Whether stiffening of the central artery is related to white matter integrity 
and cognitive function at midlife remains unknown. Our aim was to determine if 
subclinical carotid artery stiffening is associated with lower cerebral white matter 
integrity (CWMI) at midlife in a priori regions of interest (ROIs) susceptible to vascular 
and cognitive aging. Methods: A multi-racial, community dwelling, non-depressed, 
cohort of middle-aged (40-61 years) adults without clinically evident cognitive 
impairment was recruited (n=143). Simultaneous ultrasound imaging and arterial 
tonometry were used to assess carotid arterial compliance, distensibility, and the β-
stiffness index. Diffusion tensor imaging (DTI) measured fractional anisotropy (FA), and 
mean diffusivity (MD) in a priori ROIs as indices of CWMI. Executive function, 
processing speed, and memory domain scores were determined from a cognitive battery. 
Results: Anterior limb of the internal capsule (ALIC) and cingulum CWMI were 
associated with arterial stiffness metrics (p<0.05) independent of age, sex, and waist 
circumference. Cingulum FA was associated with executive function and processing 
speed (both p<0.05), and carotid artery compliance negatively affected processing speed 
indirectly through superior corona radiata MD (β=5.6, 95% CI= 0.58 to 19.14). 
Conclusions:  We identified multiple white matter regions vulnerable to the effects of 
carotid artery stiffening in midlife, including independent associations. Susceptible 
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regions were associated with executive function and processing speed with arterial 
stiffness indirectly affecting processing speed. These data suggest that arterial stiffening 
may negatively affect CWMI prior to clinically overt cognitive decline. 
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Introduction 
Stiffening of the vasculature, known as arteriosclerosis, occurs with aging and 
chronic exposure to cardiovascular risk factors (174). Arterial stiffness is characterized 
by remodeling of scaffolding proteins such that stiff collagen fibers are increased, while 
the number of flexible elastin fibers is diminished (340).  Maintenance of vascular 
elasticity is critical for maintaining Windkessel function, the ability to buffer and cushion 
pulsatile forces that accompany each heartbeat and convert them into smooth continuous 
blood flow (31). Loss of this function leaves the microvasculature vulnerable to 
damaging pulsatile stress, making end organs susceptible to hypoperfusion and hypoxic 
injury (197, 290).  
In addition to being an independent predictor of cardiovascular events, arterial 
stiffening is associated with increased risk of white matter lesions, cerebral stroke, and 
dementia in older elderly populations (193, 241, 253). Vascular dysfunction is an early 
and persistent pathological hallmark in the decline from healthy cognitive functioning to 
dementia (143). In older adults, central artery stiffening is associated with decreased 
global cognitive functioning, processing speed, and perceptual speed but not verbal 
memory (318). Consistent with this notion, individuals with vascular cognitive 
impairment appear to have weakened cognitive function with the greatest deficits to 
executive function and processing speed while memory is least affected (309). 
  Descriptive assessment of cerebral white matter integrity (CWMI) has been 
popularized since the advent of diffusion tensor imaging (DTI) because of its ability to 
characterize subtle changes of water diffusion in white matter tracts in vivo (12). 
Fractional anisotropy (FA) determined from DTI represents directional parallelism of 
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water diffusion in white matter tracts and is reflective of healthy white matter. 
Conversely, mean diffusivity (MD) represents the magnitude of water diffusion with 
greater magnitude reflective of poorer CWMI. CWMI tends to peak as early as the third 
decade of life before beginning a subtle decline in midlife from the fourth to sixth decade 
of life after which a steep decline ensues (320).  
Arterial stiffening of the cardiothoracic arteries is associated with both decreased 
CWMI and cognitive performance in healthy and cognitively impaired older adults (288).  
Additionally, arterial stiffening is related to reduced perfusion of frontal white matter 
responsible for facilitating the performance of executive function tasks (290). Taken 
together, these findings suggest that arterial stiffening, representing global vascular 
dysfunction, attenuates cerebral perfusion and compromises CWMI. Whether this 
potential mechanism operates during midlife prior to stark decline of CWMI or evidence 
of overt cognitive impairment remains unknown. Most investigations associating arterial 
stiffness to CWMI have relied upon the abdominal aorta rather than assessing the carotid 
artery and examined older populations (158, 212, 241). Ostensibly, alterations to carotid 
elasticity could more directly impact cerebral parenchyma because of its proximity to the 
cerebral circulation. 
With this information as background, the primary aim of this investigation was to 
determine if midlife stiffening of the carotid artery is associated with lower CWMI in a 
priori regions of interest (ROIs) susceptible to vascular aging. Secondly, we aimed to 
determine if carotid artery stiffening could directly or indirectly affect cognitive function. 
To accomplish these aims, robust assessment tools of ultrasound imaging and DTI 
magnetic resonance imaging sensitive to subtle alterations to white matter were 
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employed. We hypothesized that increased arterial stiffness would be negatively 
associated with DTI metrics of healthy CWMI and cognitive performance. We further 
hypothesized that arterial stiffness would negatively affect executive function and 
processing speed indirectly through CWMI. 
Methods 
Participants. A multi-ethnic sample of 143 community-dwelling men and women 
in midlife (aged 40-61 years) representative of the Austin, Texas area was recruited 
through local newspaper and online advertisements. To be eligible, participants had to 
have no pre-existing cardiovascular disease (e.g., coronary artery disease, angina 
pectoris, myocardial infarction, heart failure, and cardiac surgery), overt neurological 
disease (e.g., stroke, Parkinson’s disease, and clinically significant traumatic brain 
injury), or contraindications to MRI assessed through self-report on a health history 
questionnaire. Participants scoring >19 on the Beck Depression Inventory-II, indicating 
moderate to severe depression were excluded. All subjects provided informed consent, 
and the local institutional review board approved this study. 
Health Assessment. Participants completed a detailed health history questionnaire 
outlining medication use and current physical activity behavior. Blood samples were 
collected from the antecubital vein through venous puncture after subjects reported to the 
laboratory following an overnight fast of at least 8 hours. Plasma glucose and lipid 
concentrations were determined using standard enzymatic technique. Brachial systolic 
and diastolic blood pressures were assessed in the supine position after a 15-min period 
of rest using a blood pressure device (VP-2000; Omron Healthcare, Bannockburn, IL).  
  31 
Carotid Artery Stiffness Measurement.  A B-mode image of the left common 
carotid artery was captured longitudinally using an iE 33 Ultrasound System (Philips, 
Bothell, WA) outfitted with a high-resolution linear-array transducer. Images of the near 
and far wall interfaces were captured perpendicular to the carotid artery 1-2 cm proximal 
to the carotid bulb. Ultrasound images were digitized and saved in DICOM format for 
later analysis with computerized image-analysis software (Vascular Research Tool 
Carotid Analyzer, Medical Imaging Applications, Coralville, IA) by an investigator who 
was blinded to subject’s cardiovascular health. Simultaneously, pulse pressure 
waveforms from the contralateral common carotid artery were gathered with arterial 
applanation tonometry (VP-2000; Omron Healthcare, Kyoto, Japan). Because various 
arterial stiffness indices appear to reflect different aspects of the arterial wall property, a 
variety of arterial stiffness indices were calculated (180).  Arterial elasticity 
characteristics were described through arterial compliance and distensibility. These 
measures respectively assess the absolute and relative change in diameter of the carotid 
artery for a given pressure step at fixed vessel length (209). The β-stiffness index was 
used to determine carotid artery stiffness calculated as a stiffness measure that was 
relatively independent of distending pressure. 
DTI Acquisition. A 3T Siemens Skyra system (Siemens Medical Solutions, 
Malvern, PA) with a 32-channel head coil was used to execute MRI. To acquire images 
in 64 directions at b=700 s/mm, a diffusion-weighted, spin-echo, echo planar imaging 
pulse sequence was used. A non-diffusion weighted reference image was gathered with 
b=0. Neighboring 2 mm slices were collected anterior to posterior to cover the cerebrum 
with the following parameters: FOV = 256 mm, TR = 8,300 ms, TE = 84 ms. To 
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minimize EPI distortions and optimize the homogeneity of the magnetic field across the 
brain, advanced shimming was implemented prior to diffusion-weighted imaging.  
 Using the methods of Hui Zhang et al. (338), diffusion-weighted images were 
processed with high-dimensional normalization that employed the full tensor, instead of 
tensor-derived indices in the following processing pipeline. First, using FSL 
(http://www.fmrib.ox.ac.uk/fsl/), motion and eddy current distortions were corrected with 
affine transformations. FSL’s brain extraction tool was used to remove non-brain signal. 
FSL’s dtifit function (http://cmic.cs.ucl.ac.uk/camino/) performed tensor fitting.  
A study-specific template based on 122 participants was created using iterative 
rigid, affine, and diffeomorphic alignments of the full tensor in DTI-TK 
(http://www.nitrc.org/projects/dtitk/). Each individual’s tensor map was normalized to the 
study-specific template map using rigid, affine, and diffeomorphic alignments in DTI-
TK.  The study-specific template was then registered to standard space using the IIT 
Human Brain Atlas (www.nitrc.org/projects/iit2). Using DTI-TK, standard space FA 
maps were calculated from each subject’s tensor map. ROIs were defined in standard 
space using the Johns Hopkins International Consortium. ROIs were determined a priori 
based on existing literature as described below. Each participant’s FA map was masked 
by each ROI and the resulting FA ROIs were thresholded at 0.2 to exclude non-white 
matter signal. The average FA value from each ROI was then extracted. MD maps were 
calculated in subject space. To define ROIs in subject space, inverse deformation fields 
were calculated from standard space to subject space and applied to the ROIs.  
Region-of-Interest Determination. ROIs were established a priori for their pre-
existing reported relationships with cognitive aging, arterial stiffness, and aerobic fitness. 
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ROIs related to aerobic fitness were included because of chronic aerobic fitness has been 
shown to benefit arterial stiffening (286). The corpus callosum (CC) comprised of the 
genu, body, and splenium have been investigated as white matter regions vulnerable to 
aging (158), dementia (127), and arterial stiffening (186, 288). Arterial stiffness has also 
been related to the corona radiata and internal capsule (186, 288). Lastly, aerobic fitness 
has been associated with the cingulum, cingulum (hippocampal), and uncinate fasciculus 
(190, 191). 
Cognitive Assessment. A cognitive performance battery was administered 
containing assessments of global cognitive function, including the Mini Mental State 
Examination (MMSE), Wechsler Abbreviated Scale of Intelligence-II Full Scale 
Intelligence Quotient subtest, Beck Depression Inventory-II (BDI-II).  The executive 
function domain was characterized by study specific z-scores on the Trail Making Test A 
and B, Wechsler Adult Intelligence Scale III (WAIS-III) Digit Span subtest, and Stroop 
interference subtest.  Z-scores were inverted on timed tasks for directional congruity and 
averaged to construct an executive function domain score. Processing speed was 
measured by constructing a domain score using the same technique with the Trail Making 
Test A, Stroop word, and Stroop color tasks included. The memory domain was 
comprised of the California Verbal Learning Test (CVLT)-II short delay free recall, long 
delay free recall, and recognition discriminability tasks. Cognitive function testing lasted 
approximately one hour and was performed with research assistants trained in 
administration of these tests. The same assistants completed scoring all tests in an effort 
to maintain the highest standardization. 
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Statistical analyses. Physiological and cognitive variables were presented as 
sample means and standard deviations. The statistical analysis pipeline proceeded in three 
steps as follows. First, the relations of arterial stiffness to CWMI were determined with 
bivariate correlations. To determine the independent effect of arterial stiffness on CWMI 
in ROIs with significant bivariate correlations, general linear models adjusted for age, 
sex, and waist circumference were performed. Second, white matter regions associated 
with arterial stiffness, determined from significant bivariate correlations, were examined 
in relation to cognitive function domain z-scores by performing general linear models 
with age, sex, waist circumference and years of education entered as covariates.  Age and 
sex were included because of their known effects on CWMI (142). In addition, waist 
circumference was related to CWMI in this sample using whole brain analysis (Birdsill et 
al., unpublished data). Additional potential cardiovascular covariates (e.g., blood 
pressure, fasting glucose, triglycerides, and cholesterol) were not included as none was 
related to CWMI. Third, direct and indirect effects of arterial stiffness on cognitive 
function through CWMI were determined using non-parametric bootstrapping procedure 
in Preacher and Hayes’ SPSS Process macro (125).  Unlike mediation, a significant direct 
association between the independent and dependent variables is not required for indirect 
effects to be present. This procedure was performed only if associations existed between 
arterial stiffness and CWMI, CWMI and cognitive function, and an absence of direct 
association between arterial stiffness and cognitive function. In short, this procedure 
takes 1,000 random samples with replacement from the obtained data and calculates the 
indirect effect for each sample. 95% confidence intervals (CIs) were calculated from the 
distributions of obtained scores over the samples correcting for bias due to the underlying 
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distribution. Here, cognitive domain scores were used as dependent variables, arterial 
stiffness measures as the independent variables, and white matter metrics as the mediator. 
Age, sex, waist circumference, and years of education were included in all paths of the 
model as covariates. A 95% bias-corrected CI that excluded 0 was considered significant.  
A Bonferroni correction for multiple intercorrelated outcomes was used to 
determine the level of statistical significance (alpha p<0.02). Because the aim of this 
investigation was to determine the early or subclinical role of arterial stiffness on CWMI 
and cognitive function small effects were of interest, the uncorrected alpha p<0.05 was 
also noted in tables. SPSS version 24 (SPSS Inc; IBM, Armonk, NY) was used to 
perform all statistical analyses. 
Results 
Subject Characteristics.  Table 3.1 displays the basic physiological characteristics 
of the subject population. Participants were middle-aged, physically active, and well 
educated. Additionally, subjects were ethnically diverse (37% minority). Metabolic 
syndrome was prevalent in the sample (25.2%) with the average individual meeting 
National Heart Lung and Blood Institute and World Health Organization criteria for at 
least one component (10). Subject’s arterial stiffness and CWMI characteristics are 
delineated in Table 3.2 and Table 3.3.  
Arterial Stiffness and Fractional Anisotropy. Bivariate correlations between 
arterial stiffness indices and DTI metrics of white matters ROIs are outlined in Table 3.4. 
Anterior limb of the internal capsule (ALIC) FA was significantly associated with arterial 
compliance (r=0.23, p=0.006) and β-stiffness (r=-0.20, p=0.016). Corpus callosum (CC) 
splenium FA was trending to be associated with β-stiffness (r=-0.17, p=0.039) as was the 
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association of Cingulum FA with distensibility (r=0.17, p=0.047), while Cingulum FA 
was significantly associated with arterial compliance (r=0.25, p=0.002). All other 
relations did not achieve significance (p>0.05). 
Age, sex, and waist circumference were added as covariates to general linear 
models to ascertain the independent associations between stiffness measures and CWMI 
in regions indicated significant on bivariate analysis. These models are depicted in 
Figure 3.1a-b. In these models, ALIC FA remained significantly associated with arterial 
compliance (pr=0.22, p=0.008) and trended with β-stiffness index (r=-0.19, p=0.026). FA 
of the CC splenium lost significance with arterial distensibility (r=0.15, p=0.088). Lastly, 
cingulum FA remained significantly related to arterial compliance (r=0.22, p=0.008) and 
was trending with distensibility (r=0.17, p=0.048). 
Mean Diffusivity. From bivariate correlations, arterial compliance (r=-0.28, 
p=0.001), arterial distensibility (r=-0.28, p=0.001), and β-stiffness index (r=0.23, 
p=0.005) were all significantly associated with MD of the ALIC. Cingulum 
(hippocampal) MD was trending significance with β-stiffness (r=-0.19, p=0.026).  
Associations of superior corona radiata (SCR) MD were trending with arterial 
compliance (r=-0.16, p=0.05) and distensibility (r=-0.18, p=0.028). All other correlations 
were not significant.  
 After applying age, sex, and waist circumference as covariates to general linear 
models in instances of significant bivariate correlations, ALIC MD was significantly and 
independently associated with arterial compliance (r=-0.26, p=0.002), distensibility (r=-
0.24, p=0.005), and trending with β-stiffness index (r=-0.20, p=0.021). Associations of 
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cingulum (hippocampal) with β-stiffness index and SCR with arterial compliance and 
distensibility were abolished (p>0.05) with the introduction of covariates.   
Cognitive Function.  Executive function, processing speed, and memory were 
investigated for relations to arterial stiffness, and white matter regions demonstrating 
significant bivariate associations with arterial stiffness. Bivariate correlations of 
executive function and memory with arterial stiffness indices were not significant 
(p>0.05).  Processing speed was significantly related to arterial distensibility (r=0.20, 
p=0.017) and trending with β-stiffness index (r=0.19, p=0.023). Cingulum FA was 
significantly related to executive function (r=0.196, p=0.020) while all other regions were 
not related (p>0.05). Cingulum FA trended with (r=0.20, p=0.022), while cingulum 
(hippocampal) MD (r=-0.24, p=0.004), and SCR MD (r=-0.20, p=0.015) were each 
related to processing speed. ALIC FA, splenium FA, and ALIC MD were not associated 
with processing speed (p>0.05). 
 Age, sex, waist circumference, and years of education were added as covariates in 
general linear models to further scrutinize these relationships. Including these covariates, 
cingulum (hippocampal) MD (r=-0.22, p=0.010) remained significant and SCR MD was 
trending (r=-0.17, p=0.046) significance with processing speed while all other previously 
significant bivariate correlations were lost (p>0.05). 
Indirect Effects.  To assess the indirect effects of arterial stiffness on cognitive 
function through CWMI, non-parametric bootstrapped mediation models were employed. 
Because significant associations between β-stiffness index, cingulum (hippocampal) MD, 
and processing speed were present with covariates, the effect of arterial stiffness on 
processing speed through cingulum (hippocampal) MD was assessed. Including age, sex, 
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waist circumference, and years of education in the indirect effects model, no significant 
relation was detected (β=-0.01, 95% CI= -0.04 to 0.00). This analysis was repeated for 
arterial compliance, SCR MD, and processing speed as well as arterial distensibility, SCR 
MD, and processing speed. As displayed in Figure 3.2, the indirect path of arterial 
compliance to processing speed through SCR MD was statistically significant (β=5.6, 
95% CI= 0.58 to 19.14), although the same path with arterial distensibility was not 
(β=31.89, 95% CI= -3.65 to 98.26). 
Discussion 
The present cross-sectional investigation of community-dwelling middle-aged 
adults aimed to determine the associations of carotid artery stiffening to cerebral CWMI 
in a priori ROIs, as well as their relations with cognitive function. We found stiffening of 
the carotid artery to be significantly associated with integrity of multiple cerebral white 
matter regions vulnerable vascular dysfunction independent of age, sex, and waist 
circumference. These regions were also related to processing speed but to neither 
executive function nor memory performance after the addition of covariates. Arterial 
compliance had a significant indirect effect on processing speed through cingulum 
CWMI. This evidence, to our knowledge, is the first demonstrating midlife carotid artery 
stiffening to be negatively associated with cerebral CWMI and indirectly related to worse 
cognitive function.  
 With accumulating evidence pointing to a common vascular etiology of 
Alzheimer’s disease and vascular dementia, determining early influences of arterial 
health on the brain prior to overt cognitive symptoms may be informative particularly for 
intervention purposes (64, 137, 153). To date, most studies examining the relationship of 
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arterial stiffness, white matter health, and cognitive function have relied on aortic pulse 
wave velocity (PWV) and white matter hyperintensities showing consistent associations 
(158, 212, 241). However, the carotid artery may be more anatomically relevant to the 
cerebral circulation than the aorta, and damage to the white matter may occur prior to 
manifestation of white matter hyperintensities (47, 210).  
By measuring carotid artery stiffness, we were able to identify multiple 
associations of arterial stiffness with integrity of white matter regions in cognitively 
healthy community dwelling middle-aged adults. Meanwhile, the aforementioned studies 
were either reliant on older or clinical populations to demonstrate relations of aortic 
stiffness to CWMI or cognitive function (158, 212, 241). In older and clinical 
populations, irreversible vascular-related white matter damage may have already been 
accumulated. Investigating cognitively intact middle-aged adults allows for the detection 
of early white mater damage that may be ameliorated with clinical interventions.   
More recent investigations are reflective of a shift to using DTI as a marker of 
early white matter vulnerability in middle-aged populations before incipient cognitive 
impairment (137, 153, 234). Pulse pressure, a surrogate of arterial stiffness, is 
significantly associated with reduced CWMI in prefrontal white matter and the ALIC of 
older adults (age >64 years), as well as the CC Genu (158). An investigation of middle-
aged type 1 diabetic men yielded independent associations between aortic PWV and 
whole brain CWMI (295).  A large cross-sectional study of community dwelling middle-
aged adults detected a significant association between aortic PWV and reduced FA of the 
corpus callosum and corona radiata (186). In cognitively normal older adults and those 
with mild cognitive impairment, carotid-femoral PWV was negatively associated with 
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DTI indices of CWMI globally and within the corona radiata, internal capsule and 
superior longitudinal fasciculus (288). In the latter study, global measures of CWMI were 
significantly associated with the Trail Making Test B-A executive function task.  
The most robust relationships identified in the present study were stiffness metrics 
with the ALIC and cingulum. Damage to the ALIC is consistent with reports of an 
anterior to posterior vulnerability gradient previously observed in aging individuals and 
those with metabolic syndrome (261, 334). The ALIC bundle extends to the frontal lobe 
and white matter lesions in this region have been related to diminished executive function 
in older adults (268). Individuals with subcortical ischemic vascular disease without 
dementia exhibited diminished CWMI in the ALIC and cingulum, along with many other 
tracts (181). The absence of other regions being affected by arterial stiffness indicate that 
changes to the ALIC and cingulum may be primary to more diffuse white matter damage 
that occur further along the pathology spectrum (262, 339).   
Among the regions we identified as vulnerable to arterial stiffening, integrity of 
the cingulum and SCR was also related to processing speed, although the relation with 
SCR MD was lost with the addition of covariates. Still, arterial stiffness had a significant 
indirect effect on processing speed through SCR CWMI following non-parametric 
bootstrapping with covariates. Cingulum FA was positively associated with executive 
function and processing speed in older adults without dementia and elsewhere linked to 
information processing speed in normal aging (154, 246). Taken together, these findings 
are suggestive of a temporal relationship behind observations of arterial stiffening and 
dementia in older adults and those with cognitive complaints (120, 219, 220). It is 
possible that arterial stiffness preferentially affects regions of cerebral white matter 
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without disruption of cognitive function until the accumulation of subtle but consistent 
damages results in reduced processing speed and eventually clinically apparent 
symptoms. However, this mechanistic relationship needs further investigation and cannot 
be established from the present study.  
How arterial stiffening damages the cerebral white matter remains to be fully 
elucidated but may likely be multifactorial. As large arteries lose elasticity, their ability to 
buffer pulsations from the heart is diminished (31). The resulting mechanical stress is 
transferred to inelastic microvasculature at end organs such as the brain (135, 319). An 
environment of chronic low-grade hypoperfusion and breakdown of the blood brain 
barrier initiates inflammation resulting in stifled energy delivery and waste clearance 
(138, 256, 290). Together, these perturbations could harm oligodendrocytes and induce 
demyelination (88, 194). With myelin degeneration, oligodendrocyte’s production of 
trophic factors, including insulin-like growth factor-1 and glial-derived neurotrophic 
factor may be reduced. Loss of these neurotrophic factors causes axonal damage and 
further demyelination (324). Additionally, oligodendrocyte progenitor cells charged with 
repairing damaged WM and remyelinating axons are unable to properly mature. Fixed in 
an immature state, they are powerless to reconstruct myelin due in part to hypoxia (20, 
21, 80). Because of myelin’s critical role in facilitating action potential potentiation, its 
degradation impedes cortical communication and disrupts cognitive function. With 
enough severity, this damage becomes radiologically evident via white matter lesions or 
altered indices of CWMI as we observed with reduced FA or increased MD, perhaps 
indicating reduced myelination or membrane density as we observed (28).  
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 The current investigation benefited from a large heterogeneous sample of 
community dwelling middle-aged individuals who have yet to develop overt cognitive 
impairments. Using robust imaging techniques to determine carotid artery stiffness and 
highly sensitive DTI-MRI enabled the identification of multiple cerebral white matter 
regions demonstrating early susceptibility to arterial stiffening.  These relations are made 
possible by DTI, an imaging modality more sensitive to and descriptive of white matter 
changes than more traditionally used T2 weighted MRI (283). The assessment of the 
carotid artery in relation to CWMI and cognitive function is also advantageous compared 
with the abdominal aorta because it is more anatomically relevant to the cerebral 
circulation.  
The greatest limitation of the current study is its cross-sectional nature. As such, 
any claims of arterial stiffness directly affecting CWMI or cognitive function are 
precluded. Nonetheless, associations of arterial stiffness measures to multiple CWMI 
 regions were identified.  These relationships were not subjected to strict multiple 
comparison control.  Thus, type 1 error inflation may exist although error control was 
considered in our results and interpretation. Additionally, the strengths of the 
relationships detected may be considered small in magnitude. This is likely because we 
examined a middle-aged cohort without overt cardiovascular diseases that only exhibited 
mild arterial stiffening.  Therefore, we would expect the relationships between arterial 
stiffness and CWMI to be subtle at this early stage in the pathological process.  
 In summary, we were able to identify multiple white matter regions vulnerable to 
stiffening of the carotid artery during midlife. The most robust relation observed was 
anatomically anterior, suggesting anterior regions may be primarily degraded from 
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arterial stiffening. Arterial stiffening had an inverse indirect effect on processing speed 
through CWMI. Since the sample population was without clinically significant cognitive 
symptoms, these data suggest that arterial stiffening may contribute to early vulnerability 
of white matter until sufficient damage accumulates to result in disrupted cognitive 
function.  From an intervention perspective, lifestyle behaviors such as chronic aerobic 
exercise could potentially preserve CWMI and executive function via increased arterial 
elasticity and reduced cardiovascular risk factors (24). Longitudinal exercise intervention 
studies observing changes in arterial stiffness, CWMI, and cognition with advancing age 
may further uncover their mechanistic relationships. 
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Table 3.1 Selected subject characteristics   
    Mean ± SD 
Descriptive Age, y 48.9 ± 6.2  
 
Sex, M/F 64/79 
 
Education, years 16.3 ± 2.3 
 
BDI-II score 6.0 ± 4.5 
 
Height, cm 168 ± 9 
 
Weight, kg 80.1 ± 16.4 
 
BMI, kg/m2 28.1 ± 5.6 
 
Waist Circumference, cm 94 ± 13 
 
Systolic BP, mmHg 121 ± 13 
 
Diastolic BP, mmHg 73 ± 10 
 
Total-C, mg/dL 203 ± 43 
 
HDL-C, mg/dL 54 ± 17 
 
LDL-C, mg/dL 130 ± 38 
 
Triglycerides, mg/dL 121 ± 77 
 
Glucose, mg/dL 97 ± 26 
 
Hypertension, n (%) 16 (11.2) 
 
Hypertriglyceridemia, n (%) 46 (32.2) 
 
Low HDL, n (%) 43 (30.1) 
 
Impaired Fasting Glucose, n (%) 40 (28.0) 
 
MetS Components, n 1.6 ± 1.4 
 
MetS, n (%) 36 (25.2) 
Health Behavior MV PA, bouts/week 3.9 ± 3.2 
 
MV Time, hours/week 1.5 ± 1.7 
Sit Time, hours/week 8.0 ± 4.1 
 
Smoking, n (%) 23 (16.1) 
Ethnicity Caucasian, n (%) 90 (62.9) 
 
African American, n (%) 11 (7.7) 
 
Latino, n (%) 29 (20.3) 
 
Asian, n (%) 5 (3.5) 
 
Other, n (%) 8 (5.6) 
Medication Anti-hypertensive, n (%) 28 (19.6) 
 
Anti-cholesterol, n (%) 15 (10.5) 
 
Anti-diabetic, n (%) 4 (2.8) 
 Hormone replacement, n (%) 8 (5.6) 
BDI=Beck depression inventory, BMI=body mass index, BP=blood 
pressure, C=cholesterol, MVPA=moderate to vigorous physical activity, 
MetS=metabolic syndrome 
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Table 3.2. Arterial stiffness 
  Mean ± SD 
Arterial compliance, 100 x cm2/mm Hg  1.2 ± 0.3 
Arterial distensibility, 1000 x mm Hg-1  1.8 ± 0.5 
β-stiffness index, AU 6.5 ± 1.9 
AU=arbitrary unit 
 
Table 3.3. DTI metrics in a priori ROIs 
Measure ROI Mean ± SD 
FA ALIC 0.53 ± 0.03 
 
CC Genu 0.59 ± 0.03 
 
CC Body 0.60 ± 0.04 
 
CC Splenium 0.65 ± 0.03 
 
Cingulum 0.49 ± 0.03 
 
Cingulum (hippocampal) 0.45 ± 0.03 
 
SCR 0.45 ± 0.03 
 
Uncinate 0.46 ± 0.03 
MD ALIC 0.76 ± 0.05 
 
CC Genu 0.90 ± 0.06 
 
CC Body 1.00 ± 0.09 
 
CC Splenium 0.99 ± 0.08 
 
Cingulum 0.79 ± 0.05 
 
Cingulum (hippocampal) 0.86 ± 0.07 
 
SCR 0.77 ± 0.04 
  Uncinate 0.78 ± 0.04 
ALIC, anterior limb of internal capsule; CC, corpus 
callosum; SCR, superior corona radiata 
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 Table 3.4. Bivariate correlations between white matter ROIs and carotid artery stiffness metrics  
     ALIC 
CC 
Genu 
CC 
Body 
CC 
Splenium Cingulum 
Cingulum 
(hippocampal) SCR Uncinate 
FA AC r .025** 0.15 0.18* 0.18* 0.30** 0.12 0.08 0.12 
 Dist r 0.18* 0.14 0.16* 0.18* 0.23** 0.05 0.00 0.09 
 β-Stiff r -0.20** -0.11 -0.16* -0.16* -0.18* -0.11 -0.09 -0.03 
MD AC r -0.31** -0.05 -0.08 -0.09 -0.15 -0.14 -0.19** -0.15 
 Dist r -0.31** -0.08 -0.14 -0.14 -0.13 -0.17* -0.22** 0.14 
 β-Stiff r 0.22** -0.03 0.06 0.05 0.08 0.18* 0.13 -0.13 
AC=arterial compliance; Dist=arterial distensibility, β-Stiff=β-Stiffness index; ALIC, anterior limb of internal 
capsule; CC, corpus callosum; SCR, superior corona radiata 
*Trending at p<0.05 
**Significant with adjusted Bonferroni correction at p<0.02 
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Figure 3.1a-b. Partial correlation plots depicting significant independent associations of 
arterial stiffness with fractional anisotropy (a) and mean diffusivity (b) in a priori ROIs 
controlling for age, sex, and waist circumference. 
a) 
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b) 
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Figure 3.2.  Path model depicting the indirect effect of arterial stiffness on processing speed through white matter integrity assessed 
through non-parametric bootstrapping. SCR=superior corona radiata; *p<0.05 
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CHAPTER 4: PHYSICAL ACTIVITY MITIGATES ADVERSE 
EFFECT OF METABOLIC SYNDROME ON VASCULATURE 
AND BRAIN 
Abstract 
Background: Metabolic syndrome (MetS) adversely affects the vasculature and 
cerebral white matter (CWM) integrity. Arterial stiffening has been associated with 
diminished CWM integrity. Physical activity (PA) can ameliorate components of MetS 
and subsequently affect arterial stiffening and CWM integrity. Our aim was to 
determine the role of PA on mitigating the adverse influence of MetS on arterial 
stiffness and CWM integrity. Design: In a cross-sectional study design, sixty-six 
middle-aged adults (40-62 years) composed of 18 sedentary MetS (Sed MetS), 21 
physically active MetS (Active MetS), and 27 healthy individuals absent of MetS risk 
factors were studied. Methods: Carotid artery stiffness was assessed via simultaneous 
ultrasound and tonometry. CWM integrity was measured using diffusion tensor 
imaging (DTI) through metrics of fractional anisotropy (FA) and mean diffusivity 
(MD). Results: Carotid β-stiffness index in Active MetS was lower than Sed MetS but 
was not different from Healthy controls (6.6±1.5, 7.7±2.1, and 5.6±1.6 au, p=0.001). 
DTI indicated CWM integrity was significantly greater in Active MetS subjects 
compared to Sed MetS subjects but statistically equal to Healthy controls in the 
anterior limb of the internal capsule, body and splenium of the corpus callosum, 
uncinate fasciculus, cingulum, and superior corona radiata (all p<0.05). Conclusions: 
Middle-aged individuals with MetS who habitually perform PA demonstrated lower 
arterial stiffness and more favorable CWM integrity than their sedentary peers, 
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indicating that PA may be effective in mitigating the adverse effects of MetS on the 
vasculature and brain at midlife. 
Introduction  
Cardiovascular risk factors are frequently accumulated throughout the lifespan 
and can synergistically lead to a deleterious condition known as metabolic syndrome 
(MetS) (10). The World Health Organization has declared MetS to be a global 
epidemic (229) and over a third of U.S. adults are afflicted by MetS (6). This 
prevalence is troubling, as individuals with MetS not only demonstrate increased risk 
for cardiovascular disease, but also elevate their probability of acquiring vascular 
dementia by several fold (187, 235). 
Individuals with MetS exhibit markedly elevated arterial stiffening, as virtually 
all components of MetS have been associated with the pathogenesis of arterial 
stiffening (178, 248). Arterial stiffness is elevated in elderly individuals with cognitive 
disease and is predictive of cognitive decline (120, 219). Arterial stiffening has been 
shown to be associated with regional damage to cerebral white matter (CWM) integrity 
and reduced executive function (288). CWM plays an integral role in conducting 
neural information between cortical structures allowing the brain to work in synchrony. 
Alteration to the CWM is implicated as an early event in the development of dementia 
(242). Midlife visceral adiposity is associated with arterial stiffening and white matter 
hyperintensities representative of white matter damage foci (221, 280). Taken together, 
these findings indicate that arterial stiffening and abdominal obesity, two 
characteristics of MetS, may leave this population particularly vulnerable to early 
CWM alterations and subsequent cognitive dysfunction (329). 
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Regular physical activity (PA) can reduce arterial stiffness and attenuate or 
even abolish arterial stiffening that occurs with advancing age (37). Aerobic training 
can also reduce visceral adiposity and various risk factors for coronary heart disease 
(294, 311). These modifiable cardiovascular risk factors may contribute to carotid 
artery stiffening and CWM deterioration, making PA an attractive method to mitigate 
the adverse effects of MetS on arterial stiffening and CWM integrity. However, 
investigations of PA behavior in relation to CWM integrity are extremely limited. 
Further, the clinically important question of whether PA can simultaneously mitigate 
damage to the vasculature and CWM due to MetS has never been addressed.  
Accordingly, the primary aim of the present investigation was to determine 
whether individuals with MetS who are physically active demonstrate lower arterial 
stiffness and more favorable CWM integrity than their sedentary peers.  We measured 
arterial stiffness using a robust imaging-based technique of the carotid artery because 
of its anatomical relevance to cerebral circulation.  CWM integrity was determined 
using diffusion tensor imaging (DTI). DTI is a magnetic resonance imaging (MRI) 
sequence that characterizes the diffusion of water in tissue by producing scalar metrics 
capable of describing CWM integrity in vivo when applied to CWM tracts (12). 
Increased fractional anisotropy (FA) or reduced mean diffusivity (MD) are reflective 
of greater CWM integrity (12). In short, arterial stiffness, CWM, and cognitive 
function were compared in healthy controls and groups of MetS subjects who were 
either physically active or not. Our working hypothesis was that MetS subjects who are 
physically active do not demonstrate arterial stiffening and reduced CWM integrity. 
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Methods 
Participants. Community dwelling adults (n=171) aged 40-62 years were recruited 
for this investigation. For inclusion, individuals were without pre-existing overt 
cardiovascular, neurological disease, or contraindications to MRI. Of these 
participants, only individuals who were not significantly depressed as determined by 
scoring <27 on the Beck Depression Inventory-II (BDI-II) or suffering from cognitive 
impairment as determined by scoring <23 on the Mini-Mental State Exam were 
included. The current analysis comprised only of subjects with metabolic syndrome 
and Healthy controls. These criteria resulted in the admission of 66 participants, who 
gave their informed consent. The local institutional review board approved this study.  
Metabolic Syndrome Characterization. To be categorized as having MetS, 
participants were required to have 3 or more of the following components:  abdominal 
obesity denoted by waist circumference ≥94 cm for men and ≥80 cm for women; 
elevated triglycerides (≥150 mg/dL); reduced HDL cholesterol (<40 mg/dL for men 
and <50 mg/dL for women); increased blood pressure defined as systolic blood 
pressure ≥130mm Hg and/or diastolic blood pressure ≥85mm Hg; hyperglycemia of 
elevated fasting glucose (≥100 mg/dL); pharmacological intervention for any condition 
above (10, 325). 
All subjects reported for vascular assessments in the morning after having 
fasted overnight for at least 8 hours and abstained from physical exercise, alcohol 
consumption, and caffeine for at least 24 hours. An elastic measuring tape was placed 
around the trunk at the top of the iliac crest to measure waist circumference. Standard 
enzymatic techniques were used to quantify blood concentrations of triglycerides, 
HDL-cholesterol, and glucose. Blood pressure was assessed using the automatic 
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oscillometric methods (VP-2000; Omron Healthcare, Kyoto, Japan) in the supine 
position after comfortably resting for 15 minutes in a temperature controlled laboratory 
setting.  
  Arterial Stiffness Measurement. A longitudinal B-mode image of the common carotid 
artery was acquired using an iE 33 Ultrasound System (Philips, Bothell, WA) equipped 
with a high-resolution linear-array transducer. Images were captured 1-2 cm proximal 
to the carotid bulb perpendicularly to the blood vessel. Digitized images acquired via 
ultrasound were analyzed with computerized image-analysis software (Carotid 
Analyzer, Medical Imaging Applications, Coralville, IA) by a single investigator. 
Concurrent recordings of pulse pressure waveforms from the contralateral common 
carotid artery were obtained with arterial applanation tonometry (VP-2000; Omron 
Healthcare, Kyoto, Japan). Carotid artery compliance and arterial distensibility 
describe the absolute and relative change in diameter of the vessel for a given pressure 
step at fixed vessel length(209). β-stiffness was calculated as a measure of carotid 
stiffness independent of distending pressure.  
DTI Acquisition. MRI was performed using a 3T Siemens Skyra system 
(Siemens Medical Solutions, Malvern, PA) with a 32-channel head coil. A diffusion-
weighted, spin-echo, echo planar imaging pulse sequence was used to acquire images 
in 64 directions at b=700 s/mm. One image with b=0 was collected for a non-diffusion 
weighted reference image. Diffusion-weighted images underwent high-dimensional 
normalization (338). Motion and eddy current distortions were corrected with affine 
transformations in FSL (http://www.fmrib.ox.ac.uk/fsl/). Non-brain signal was 
removed using FSL’s brain extraction tool. Tensor fitting was performed using FSL’s 
dtifit function (http://cmic.cs.ucl.ac.uk/camino/). Participant tensor maps were 
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normalized to the study-specific template map using rigid, affine, and diffeomorphic 
alignments in DTI-TK (http://www.nitrc.org/projects/dtitk/).  The study-specific 
template was then registered to standard space using the IIT Human Brain Atlas 
(www.nitrc.org/projects/iit2) where FA maps were calculated with DTI-TK. Regions-
of-interest (ROIs) were determined a priori based on existing literature and included 
corpus callosum (CC) segments, superior corona radiata (SCR), anterior limb of the 
internal capsule (ALIC), cingulum, cingulum (hippocampal), and uncinate fasciculus 
for their relations to abnormal cognitive aging (158), dementia (127), arterial stiffening 
(288), and aerobic fitness (191). 
Cognitive Assessment. Encompassed in the battery was the Mini Mental State 
Examination (MMSE), Wechsler Abbreviated Scale of Intelligence-II Full Scale 
Intelligence Quotient-2 subtest and Beck Depression Inventory-II (BDI-II). Domain z 
scores were constructed for executive function, processing speed and memory.  The 
executive function domain was constructed from the Trail Making Test A and B, 
Wechsler Adult Intelligence Scale III (WAIS-III) Digit Span subtest, and Stroop 
interference subtest. Included in the processing speed domain were the Trail Making 
Test A, Stroop word, and Stroop color tasks. The memory domain was comprised of 
the California Verbal Learning Test (CVLT)-II short delay free recall, long delay free 
recall, and recognition discriminability tasks. Z scores of each task were inverted 
where appropriate (e.g., time-based tasks) for directional congruity and averaged to 
create domain scores. To foster testing standardization, the same assistants performed 
all scoring. 
Physical Activity Behavior.  Participants reported days of engaging in low, 
moderate, and vigorous intensity PA for intervals of at least 15-minute during free time 
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in a 7-day period using the same classifications as the Godin leisure-time physical 
activity questionnaire (97). Low PA was defined as “minimal effort” (e.g. yoga, 
archery, bowling etc.), moderate PA was defined as “not exhausting” (e.g. fast 
walking, baseball, tennis etc.), and vigorous PA was described as “heart beats rapidly” 
(e.g. running, hockey, football, soccer etc.). This questionnaire has a high two week 
retest reliability coefficient of 0.94 (97). 
 Group stratification.  The subject population was first stratified by MetS 
components. Individuals with ≥3 MetS components created a MetS cohort that was 
further separated into sedentary (Sed MetS, n=18) and active (Active MetS, n=21) 
groups based on a median split of self-reported frequency of moderate to vigorous PA.  
The Sed MetS cohort was described as sedentary because of the paucity of PA this low 
group displayed following the median split. Individuals without MetS components 
populated the Healthy control group (n=27). 
  Statistical Analyses. Differences for categorical variables between groups 
were determined using Chi Square test while group differences in scalar variables were 
measured using analysis of variance. Covariates (e.g. age and sex) were considered but 
did not significantly affect results and were thus not included. Variable 
homoscedasticity across groups for arterial stiffness and DTI outcomes was assessed 
with Levene’s test with all passing as p>0.05 except arterial distensibility (p=0.039). 
Significant F-values were further analyzed with least significant difference post-hoc 
examination to determine group differences. Because small effects were of interest for 
clinical implications, a Bonferroni correction for multiple intercorrelated outcomes was 
used to determine the level of significance in DTI metrics, leading to an α<0.02 
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selected for statistical significance. SPSS version 24 (SPSS Inc; IBM, Armonk, NY) 
was used to perform all statistical analyses.  
Results 
Group Characteristics. As presented in Table 4.1, both MetS groups had 
greater waist circumference, systolic BP, triglyceride, blood glucose and lower HDL-
cholesterol than healthy controls and did not differ from each other except for 
triglycerides (all p<0.05). Frequency of PA was lower in the Sed MetS group 
compared with Healthy controls and the Active MetS group (all p<0.05). Physical 
activity did not differ between the Healthy control and Active MetS groups and 
reached the ACSM frequency guidelines for PA.(224) Ethnicity was evenly distributed 
amongst groups (p>0.05). 
Arterial Stiffness.  As shown in Figure 4.1, carotid artery compliance was 
highest in Healthy controls and lowest in the Sed MetS group (all p<0.05). However, 
no differences in arterial compliance existed between MetS groups. Arterial 
distensibility was greatest in the Healthy control group compared to either Active MetS 
or Sed MetS group (all p<0.05). The Active and Sed MetS groups did not demonstrate 
statistically different arterial distensibility. β-stiffness index was significantly lower in 
the Active MetS group compared with the Sed MetS group and was not different from 
Healthy controls. 
White-Matter Integrity. As shown in Table 4.2, CC genu FA was significantly 
greater in Active MetS compared to Sed MetS but not different than Healthy controls. 
In the CC body, CC splenium, cingulum, and uncinate, both Active MetS and Healthy 
controls demonstrated greater FA than Sed MetS and were statistically different from 
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each other (all p>0.05). This trend is demonstrated in Figure 4.2 using CWM integrity  
means. 
 No group differences were detected in the CC genu, body, or splenium MD (all 
p>0.05). Alternatively, cingulum (hippocampal) MD was statistically lower in Active 
MetS compared with Sed MetS group and not different from Healthy. Remaining ROIs 
including the ALIC, cingulum, SCR, and uncinate all showed the same pattern of 
significantly lower MD in both Active MetS and Healthy controls compared with Sed 
MetS (all p<0.05). Active MetS and Healthy controls were not significantly different in 
these ROIs.  
Cognitive Function.  As shown in Table 4.1, cognitive performance was 
similar across groups on the MMSE and WASI FSIQ - 2 subtests. No differences were 
observed between groups on executive function or memory performance across groups 
(all p>0.05). Processing speed was greater in Active MetS compared with Sed MetS 
group (0.1 au ± 0.6 vs. -0.3 au ± 0.5 p=0.037) and not different from Healthy controls 
(0.2 au ± 0.5, p>0.604). 
Discussion 
The principle findings from the present study are as follows. First, sedentary 
individuals with MetS exhibited increased arterial stiffening and diminished CWM 
integrity, indicating MetS-associated increases in arterial stiffness and CWM integrity 
vulnerability. Second, individuals with MetS who performed greater PA had arterial 
stiffness and CWM integrity comparable with healthy controls. These findings indicate 
that PA may assuage arterial stiffening while protecting CWM integrity in individuals 
with MetS.  
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Investigations relating PA to CWM integrity are few with a greater proportion 
of existing literature focusing on exercise and cardiorespiratory fitness. A prior 
investigation reported PA was not related to a reduced rate of white matter lesion 
progression in a sample of elderly individual with a spectrum of cognitive impairment 
(227). However, a comparison of physically active individuals demonstrated protection 
to CWM integrity from carrying the APOE4 gene, a genetic marker of heightened 
Alzheimer’s disease risk (269). In a similar construct, our results are the first to 
directly relate PA frequency with CWM integrity in individuals with MetS. In the 
current study, it appears engaging in moderate to vigorous PA was capable of 
protecting or ameliorating the adverse effects of MetS on arterial stiffening and CWM 
integrity.  Thus, PA represents an attractive method to improve aerobic fitness, arterial 
health, and brain structure. 
A unique aspect of the current investigation is the use of a middle-aged MetS 
population that is particularly vulnerable to arterial stiffening, diminished CWM 
health, and cognition. We demonstrated that individuals with MetS even at midlife 
could perform relatively short bouts of moderate to vigorous PA to protect against 
arterial stiffening and negative CWM changes. The modesty of the mean frequency 
and duration of PA performed by the Active MetS group is encouraging in that 
clinically relevant benefits to the vasculature and CWM can be achieved without 
overly exhaustive efforts.  
The exact mechanisms by which PA enriches CWM integrity remain elusive 
and are likely complex. PA can improve aerobic fitness, which positively correlates 
with increased CWM integrity (150, 313). Another probable factor is improving 
arterial stiffness. Dysregulation of the Windkessel effect results in exposure of small 
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vessels to pulsatility that enhances arterial stiffening through the loss of elastin and 
inflict damage to end organs such as the brain (196). If this pulsatility is transferred to 
cerebral microvessels incapable of accommodating mechanical stress, atherogenic and 
inflammatory responses that impair microvascular reactivity may result (135). Such 
changes can reduce cerebral blood flow to white and gray matter in the brain thereby 
limiting essential nutrients and prompt intermittent ischemic-like conditions (290). 
This phenomenon of reduced cerebral perfusion has been observed in individuals with 
MetS (34).   
The present study benefited from the distinctive and well-characterized subject 
population of healthy individuals and those with MetS. Middle-aged adults without 
cardiovascular risk factors are increasingly sparse. Additionally, the MetS groups were 
statistically similar in physiological characteristics outside of the independent variable 
of PA. Methodologically, the assessment of arterial stiffness via ultrasound and CWM 
integrity via DTI are reliable and robust with DTI particularly suitable for its increased 
sensitivity to CWM changes compared with other conventional structural MRI 
techniques (210). This characteristic is critical as changes to the CWM at midlife are 
likely small but could be indicative of early neuropathology. 
There are several study limitations that must be addressed. Inherent to any 
cross-sectional investigation is the inability to make causal inferences. We cannot 
specifically assert that PA was solely responsible for these findings, as external factors 
(e.g. social networks, genetics, etc.) may have influenced the differences of arterial 
stiffness and CWM integrity (199, 223, 291). Nonetheless, the groups were well 
characterized and similar across key confounders. Second, characterization of PA from 
a self-reported questionnaire is vulnerable to reporting bias and retest variability. 
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Ideally, activity monitors would be given to participants to more accurately distinguish 
PA behavior. However, dichotomizing moderate to vigorous PA frequency within our 
sample resulted in largely disparate PA between MetS groups. The Active MetS group 
seemingly met the ACSM guideline of frequency of PA, while the Sed MetS was 
nearly entirely inactive. Including a measure of aerobic fitness would have 
strengthened this investigation. However, we aimed to examine the role of physical 
activity in the vasculature and brain.  Lastly, type-1 error inflation is possible in this 
study. To combat this, we noted a reduced alpha of α<0.02 from the conventional 
α<0.05, and it was deemed clinically valuable to identify potentially vulnerable CWM 
regions.  
Our findings provide novel evidence that PA is associated with more favorable 
vascular and CWM integrity outcomes in middle-aged adults with MetS. These results 
reinforce the implication that arterial stiffening could be a mechanistic contributor to 
reduced cerebral CWM integrity in middle-aged individuals with cardiovascular risk 
factors and MetS vulnerable for future cognitive decline. 
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Table 4.1. Selected group characteristics   
    
Healthy 
Controls 
Sedentary Active 
P-value 
MetS MetS 
Descriptive Age, y 50.3 ± 6.5 49.3 ± 6.3 49.5 ± 7.1 0.882 
 
Sex, M/F 14/13 9-Sep 9-Dec 0.894 
 
Education, year 17 ± 2 16 ± 3 15 ± 2 0.137 
 
Height, cm 170 ± 8 170 ± 10 172 ± 8 0.846 
 
Body Weight, kg 68.0 ± 7.7† 90.7 ± 18.9* 94.9 ± 13.7* <0.001 
 
BMI, kg/m2 23.5 ± 2.3† 31.3 ± 6.0* 32.4 ± 5.4* <0.001 
 
Systolic BP, mmHg 114 ± 7† 124 ± 11* 127 ± 15* 0.001 
 
Diastolic BP, mmHg 70 ± 6 71 ± 8 73 ± 12 0.919 
 
Total-C, mg/dL 200 ± 34 193 ± 50 217 ± 44 0.206 
 
HDL-C, mg/dL 62 ± 14† 40 ± 13* 45 ± 19* <0.001 
 
LDL-C, mg/dL 128 ± 36 121 ± 43 130 ± 40 0.800 
 
Triglyceride, mg/dL 71 ± 27† 150 ± 62* 212 ± 109*† <0.001 
 
Glucose, mg/dL 86 ± 7† 115 ± 44* 114 ± 32* 0.001 
 
HbA1c, % 5.3 ± 0.3 6.3 ± 1.7* 6.2 ± 1.9* 0.034 
 
Waist Circumference, cm 83 ± 7† 106 ± 8* 108 ± 10* <0.001 
 
Post-menopause, n (%) 4 (15) 5 (28) 6 (29) 0.563 
Health MVPA, bouts/week 4.6 ± 3.1† 0.1 ± 0.2* 4.6 ± 2.4† <0.001 
Behavior MVPA, hours/week 1.7 ± 1.7† 0.1 ± 0.3* 1.3 ± 1.1† <0.001 
 
Sit Time, hours/day 7.5 ± 4.2 9.5 ± 4.7 7.2 ± 4.3 0.222 
 
Smoking, n (%) 6 (9.1) 2 (3.0) 3 (4.5) 0.568 
Ethnicity Caucasian, n (%) 18 (27.3) 11 (16.7) 13 (19.7) 0.825 
 
African American, n (%) 1 (1.5) 1 (1.5) 1 (1.5) 0.825 
 
Latino, n (%) 7 (10.6) 4 (6.1) 7 (10.6) 0.825 
 
Asian, n (%) 0 (0.0) 1 (1.5) 0 (0.0) 0.825 
 
Other, n (%) 1 (1.5) 1 (1.5) 0 (0.0) 0.825 
Medication Anti-Hypertensive, n (%) 0 (0.0)† 6 (9.1)* 8 (12.1)* 0.002 
 
Anti-Cholesterol, n (%) 0 (0.0) 6 (9.1)* 7 (10.6)* 0.004 
 
Insulin, n (%) 0 (0.0) 2 (3.0) 2 (3.0) 0.224 
Cognitive  MMSE 29 ± 2 29 ± 1 28 ± 2 0.514 
Function BDI-II total 5.7 ± 4.8 8.9 ± 5.5 7.0 ± 5.2 0.118 
 
WASI FSIQ - 2 subtest 114 ± 13 116 ± 16 111 ± 14 0.518 
 
Executive function, z score -0.6 ± 3.3 -0.3 ± 1.1 0.2 ± 5.3 0.744 
 
Processing speed, z score 0.2 ± 0.5 -0.3 ± 0.5‡ 0.1 ± 0.6 0.027* 
 Memory, z score 0.3 ± 0.8 -0.0 ± 0.9 -0.3 ± 0.7 0.063 
Data are means ± SD. MetS=metabolic syndrome, BMI=body mass index, BP=blood pressure, 
C=cholesterol, MVPA=moderate to vigorous physical activity, MMSE=mini mental state exam, 
BDI=Beck Depression inventory, WASI FSIQ=Wescheler adult scale of intelligence full scale 
intelligence quotient 
*Significantly different from Healthy controls.   
  †Significantly different from Sedentary MetS. 
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Table 4.2. Mean DTI white matter integrity coefficients in regions-of-interest 
Measure Region 
Healthy 
Controls 
Sedentary 
MetS 
Active 
MetS 
  P-value 
FA ALIC 0.53 ± 0.03 0.52 ± 0.03 0.54 ± 0.03 0.123 
 
CC Genu 0.60 ± 0.02 0.58 ± 0.03 0.60 ± 0.03† 0.039 
 
CC Body 0.60 ± 0.03 0.58 ± 0.04‡ 0.61 ± 0.04 0.041 
 
CC Splenium 0.66 ± 0.03 0.64 ± 0.02‡ 0.67 ± 0.03 0.010 
 
Cingulum 0.50 ± 0.03 0.47 ± 0.03‡ 0.50 ± 0.04 0.022 
 
Cingulum (hippocampal) 0.46 ± 0.03 0.44 ± 0.03 0.46 ± 0.04 0.068 
 
SCR 0.45 ± 0.02 0.45 ± 0.05 0.44 ± 0.03 0.840 
 
Uncinate 0.46 ± 0.04 0.44 ± 0.03‡ 0.47 ± 0.03 0.012 
MD ALIC 0.76 ± 0.05 0.80 ± 0.04‡ 0.76 ± 0.05 0.005 
 
CC Genu 0.90 ± 0.06 0.92 ± 0.07 0.88 ± 0.06 0.141 
 
CC Body 1.00 ± 0.08 1.05 ± 0.12 0.99 ± 0.08 0.168 
 
CC Splenium 1.01 ± 0.09 1.04 ± 0.09 0.98 ± 0.09 0.192 
 
Cingulum 0.79 ± 0.04 0.82 ± 0.03‡ 0.78 ± 0.04 0.025 
 
Cingulum(hippocampal) 0.86 ± 0.06 0.90 ± 0.05 0.85 ± 0.06† 0.039 
 
SCR 0.77 ± 0.03 0.80 ± 0.05‡ 0.76 ± 0.04 0.014 
 Uncinate 0.77 ± 0.04 0.81 ± 0.03‡ 0.77 ± 0.04 0.001 
Data are means ± SD. MetS=metabolic syndrome, FA=Fractional anisotropy, MD=Mean 
diffusivity, ALIC=Anterior Limb of Internal Capsule, CC=Corpus callosum, SCR=Superior 
corona radiata 
†Significantly different from Sedentary MetS.  
‡Significanlty different from Healthy Controls and Active MetS. 
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Figure Legends 
Figure 4.1. Carotid artery stiffness shown in Healthy Controls and Sedentary and 
Active  individuals with MetS. Data are shown as means ± SEM. *Indicates 
significantly different from Healthy Controls. ‡Indicates significantly different from 
Healthy Controls and Active MetS. 
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Figure 4.2. Representation of differences in white matter regions-of –interest 
fractional anisotropy and mean diffusivity displaying preserved microstructural 
integrity in active individuals with MetS. Data are shown as means ± SEM. ‡Indicates 
significantly different from Healthy Controls and Active MetS.  
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CHAPTER 5: REVIEW OF LITERATURE 
Dementia: Subtypes and Prevalence 
Dementia is an extremely debilitating disease that hinders the ability to perform 
activities of daily living while robbing their memory of a lifetime of experiences.  Of 
individuals with dementia, 60-80% present with abnormalities characteristic of 
Alzheimer’s disease (AD), such as amyloid-β plaque and neurofibrillary tangles of tau 
protein. Approximately 50% display some sign of vascular dementia (VaD), as 
evidenced by cerebral infarcts (18). Representing the most common form of dementia, 
AD prevalence is projected to increase in the United States nearly three fold from 4.7 
million individuals diagnosed in 2010 to 13.8 million in 2050, amounting to one new 
diagnosis every 33 seconds (128).  Against significant efforts to prevent and reduce 
common causes of deaths, deaths attributed to AD increased 71% from 2000 to 2013, 
elevating the disease to be the 6th leading cause of death in the U.S. (18) and making 
dementia a pressing public health problem.  
  Presently, there is no restorative treatment for dementia. Thus, the 
development of preventive strategies is imperative to stem the rise of dementia 
prevalence and attenuate symptom severity (64). To adapt the best preventive 
strategies, understanding temporal relationships of dementia biomarkers to disease 
pathogenesis is crucial.  The complexity of dementia etiology is daunting in that 
tracing its source is difficult, yet presents multiple opportunities for targeted treatment. 
Currently there are two major competing hypotheses surrounding the development of 
dementia: vascular and amyloid. While they possess seemingly separate 
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pathophysiology, they may work synergistically to lead to the common end result of 
dementia.  
Mechanisms of Dementia 
Although there are multiple factors associated with causing dementia, the leading 
candidates are amyloid-β, tau protein misfolding, and vascular dysregulation (145, 
153).  While these mechanisms have been viewed as distinct causes of dementia 
subtypes (63), it is evident that they are interrelated as hallmark features of AD and 
VaD are evident 50% of all dementia cases, representing mixed dementia (18).  More 
recently, a multifactorial data-driven analysis spatiotemporally assessed alterations of 
amyloid-β levels, metabolism, vascular regulation, functional activity at rest, structural 
tissue properties, and protein levels in relation to late onset Alzheimer’s disease 
progression. Findings revealed vascular dysregulation to be a key early and persistent 
event in disease progression (143). Because of its early and continued dysregulation, 
vascular function represents a crucial target for the primary prevention of cognitive 
dysfunction at midlife.  
VASCULAR MECHANISMS 
  The role of the vascular system in dementia progression has long been 
hypothesized, dating back to the early 1900s (138). Considering cerebral perfusion 
must match oxygen and energy demands of the brain, a vascular etiology of dementia 
seems logical. Because of the brain’s reliance on cerebral perfusion, blood delivery is 
normally a highly regulated system where the neurovascular unit, comprised of 
vascular cells such as endothelium and pericytes, glial cells, and neurons that maintain 
the blood brain barrier (BBB), is tightly synchronized (341). Cardiovascular risk 
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factors, including obesity, hypertension, diabetes, dyslipidemia, and smoking, insult 
this unit over time, beginning a negative series of events, including vascular 
dysfunction, atherosclerosis, and arteriosclerosis (342). When these cardioavascular 
risk factors cluster in a single individual at defined subclinical cuttoffs, it is termed 
metabolic syndrome (MetS) (10), which is associated with damage to the brain (332).   
  Cardiovascular risk factors impair endothelial function, cerebral 
autoregulation, and neurovascular function. Endothelial cells are vital in maintaining 
vascular tone and reacting to changes in arterial pressure to ensure continuous cerebral 
blood flow (51). Cerebral endothelial cells are joined by tight junctions that help 
ensure BBB integrity (76). As insults to the vasculature stemming from cardiovascular 
risk factors accumulate, oligemia and breakdown of the BBB begins (65, 300).  
Leakiness of the BBB allows for extroversion of plasma proteins such as fibrinogen, 
albumin, and immunoglobulins (8, 9). Glial cells detect these proteins and become 
activated leading to the production of reactive oxygen species that further degrade 
endothelial cells (263).  Vascular damage from reactive oxygen species is additive to 
the oxidative stress already produced by cardiovascular risk factors and cerebral 
hypoperfusion (53, 139, 141). Tissue hypoxia and oxidative stress induced by cerebral 
hypoperfusion signal the production of inflammatory cytokines, including tumor 
necrosis factor and interleukins among others (35).  
  Arteriosclerosis of larger, central vessels may also produce effects similar to 
cerebral hypoperfusion (290). Larger central vessels, such as the carotid artery, 
eventually feed cerebral microvessels, which perfuse the deep white matter of the 
brain. A fundamental function of large vessels is to buffer hemodynamic pulsatility 
and transfer smooth continuous blood flow from the heart to the systemic vasculature 
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(205). This cushioning effect of the large vessels is known as the Windkessel model. 
Dysregulation of Windkessel function results in exposure of small vessels to pulsatility 
and inflicts damage to distal-end organs, such as the brain (196). Chronic exposure to 
this pulsatility may invite atherogenic and inflammatory responses that impair 
microvascular reactivity.  Such changes can reduce cerebral blood flow to white and 
grey matter in the brain thereby limiting essential nutrients and prompting intermittent 
ischemic-like conditions (247, 290). 
  These mechanisms converge to reduce cerebral blood flow, beginning 
insidiously as oligemia and eventually progressing to ischemia causing slow 
neurodegeneration of cerebral white and grey matter (43, 69, 342).  In addition to 
providing the brain with nutrients, the cerebrovascular system is also responsible for 
cleansing superfluous amyloid-β (137). Over accumulation of amyloid-β is 
neurodegenerative, impairs cerebrovascular function, and limits cerebral blood flow (4, 
207, 293). Cardiovascular risk factors, cerebral hypoperfusion, and amyloid-β, and 
other mechanistic contributors are all associated with disruptions of cognitive function 
(29, 101, 134, 276).  
  Typically, AD presents with accumulation of amyloid-β, degeneration in the 
medial temporal lope, and memory loss while VaD is characterized by ischemia, 
frontal grey matter atrophy, and reduced executive function (165). Although memory 
is the most clinically noticeable change with medial temporal lobe atrophy, language 
comprehension, behavior, and attention are also affected. Detriments to frontal grey 
matter can affect decision-making, judgment, attention, and problem solving, all of 
which fall under the umbrella of executive function. In spite of distinct differences in 
their clinical presentations, the causal mechanisms of AD and VaD appear intertwined. 
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With either disease, identification of biomarkers, early in dementia progression when 
damage is still reversible, can lead to prevention/treatment targets. An important 
correlate of cognitive function and emerging early biomarker of AD and VaD is the 
health of the cerebral white matter (19, 33, 175, 242).  
CEREBRAL CIRCULATION 
The brain is a notoriously metabolically demanding organ, weighing only 2% 
of the body weight, yet receiving 15% of the cardiac output and 20% of the oxygen 
used by the body at rest. A complex circulatory network exists to accommodate this 
demand. The cerebral circulation originates from the left and right internal carotid 
arteries as well as the vertebral arteries. Building from the internal carotid arteries is 
the Circle of Willis, an anastomosis consisting of the bilateral anterior and posterior 
communicating and cerebral arteries as well as the basilar artery. Branching from the 
Circle of Willis are multiple vessels that lead to both hemispheres bilaterally including 
the left and right middle cerebral arteries that flow into smaller arteries, extrinsically 
innervated pial arteries that run across the surface of the brain before penetrating to 
deliver blood to the cortex and subcortical structures. For example, the middle cerebral 
artery is a principal contributor to cortex and white matter blood supply, including the 
frontal, parietal, and occipital lobes along with the insula. To supply interred white 
matter and diencephalic structures, extraparenchymal pial arteries further branch 
perpendicularly to the cerebral surface into intrinsically innervated pial arterioles that 
are separated from the brain tissue by the Virchow-Robin space that diminishes with 
depth (225).  As pial arterioles dive deeper, they contact neural tissue and astrocytes. 
The triad of vascular cells, neurons, and astrocytes interacting together comprise a 
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functional neurovascular unit capable of directing blood flow in response to neural 
activation and to meet metabolic demands (137). At each step of reduced vessel lumen 
diameter, vascular resistance and susceptibility to pulsatile flow increases. Although 
the cortex has almost four fold greater demand for cerebral blood flow, the white 
matter is also metabolically demanding. 
Cerebral White Matter  
ANATOMY 
  Cerebral white matter (WM) is interred beneath the cortical exterior forming 
~50% of the total volume of a healthy human brain (117). The principle duty of the 
cerebral WM is to conduct neural information between grey matter regions allowing 
the cortices to work synchronously. To accomplish this function, the WM is organized 
into axon bundles wrapped with myelin that accelerates action potential propagation by 
100 fold (202, 203). Although there are many classifications for WM bundles, they are 
predominantly organized into three major fiber groups. Commissural fibers bridge the 
cerebral hemispheres and include the corpus callosum. Projection fibers link the spinal 
cord, diencephalic, and mesencephalic structures with the cortex in long ascending and 
descending pathways and include such fibers as the corona radiate and anterior internal 
capsule (188). Association fibers are divided into short fibers that connect neighboring 
cortices and long fibers that unite remote grey matter. Other anatomical terms are often 
encountered when describing WM. Periventricular WM refers to WM near the lateral 
ventricles while deep WM refers to the other fibers.  Subcortical WM refers to both. 
WM is particularly vulnerable to vascular damage that leads to cognitive dysfunction 
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and dementia. Lesions to the WM are associated with hypoperfusion and ischemia 
(33).  
PATHOLOGY 
  Damage to the white matter is conferred in a multitude of ways including 
through cardiovascular risk factors and vascular dysfunction. Vascular perturbations 
disrupt cerebral perfusion, prompt BBB breakdown, initiate inflammation, and 
promote reactive oxygen species formation. Together, they harm oligodendrocytes and 
induce demyelination (88, 194). With myelin degeneration, oligodendrocyte’s 
production of trophic factors, including insulin-like growth factor-1 and glial-derived 
neurotrophic factor is attenuated. Loss of these neurotrophic factors causes axonal 
damage and further demyelination (324). Additionally, oligodendrocyte progenitor 
cells charged with repairing damaged WM and remyelinating axons are unable to 
properly mature. Stuck in an immature state, they are powerless to reconstruct myelin 
due to hypoxia (20, 21, 80). Because of myelin’s critical role in facilitating action 
potential potentiation, its degradation impedes cortical communication and disrupts 
cognitive function. Estimates of WM damage can be obtained through structural 
magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI). 
WHITE MATTER HYPERINTENSITIES 
  White matter hyperintensities (WMH) are the most common radiological 
evidence of white matter lesions. These lesions appear on T2-weighted MR images as 
bright spots that begin as punctate and become more confluent with advancing 
pathology (188).  These lesions can be the result of multiple diseases but are the most 
common feature of vascular cognitive impairment in relation to alterations of 
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microvasculature (148, 299). These lesions are reflective of rarefication of white 
matter and are associated with axonal loss, demyelination, microvascular 
arteriosclerosis, and endothelial dysfunction (42, 82, 250). The best predictor of WMH 
is age (66) and other predictors include hypertension, obesity, dyslipidemia, and 
dysglycemia (3, 39, 314). These cardiovascular risk factors can be targeted and altered 
through behavior modification and pharmacological interventions throughout the 
lifespan making them attractive treatment targets. WMH are thought to be foci of 
underlying small vessel disease, leaving the possibility that WM impairments may 
manifest even prior to the emergence of WMH. Therefore, assessment of both WMH 
and WM integrity is integral to understanding the early changes of vascular-related 
WM dysfunction.  
QUANTIFICATION OF WHITE MATTER HYPERINTENSITIES 
  The most prominent imaging modality to monitor white matter status is 
structural MRI. T1-weighted MRI, in combination with fluid attenuated inverse 
recovery (FLAIR) sequences, produce excellent anatomic resolution allowing for 
identification of WMH. Quantifying WMH volume can be accomplished in a number 
of ways. Simple visual ratings of WMH severity can be performed but is limited by 
converting a scalar variable into one that is categorical, thereby reducing data variance 
and sensitivity (188). Various visual rating scales have been constructed to increase 
sensitivity, yet the aforementioned limitations remain along with the problem of 
interrater reliability. Alternatively, computerized, automated methods to estimate 
WMH volume have been developed. Thresholding evaluates pixel intensity values and 
can sum the number of pixels that achieve a predetermined threshold (244). A seed-
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growing technique, in which investigators interactively select regions of interest, run 
an algorithm growing the seed, and identify the total number pixels of similar intensity 
can be used (266). Lastly, lesions can be manually traced. Regardless of the method 
used, expression of WMH volume should be reported in relation to total intracranial 
volume to account for differences between individuals. 
WHITE MATTER VULNERABILITY 
  White matter hyperintensities can be visually obvious radiologically, yet 
white matter integrity may be compromised prior to their manifestation (47, 210). To 
capture an earlier glimpse into WM vulnerability, diffusion tensor imaging (DTI) is 
used. DTI describes the underlying microstructure of WM by measuring the magnitude 
and direction of water molecules (26). In healthy intact WM, water encounters cellular 
barriers, including myelin, that restrict its movement (12). Conversely, in the event of 
tissue breakdown, water does not encounter such barriers and diffuses unimpeded. 
Scalar metrics are intensively computed to characterize this water diffusion. Mean 
diffusivity (MD) represents the apparent diffusion coefficient irrespective of direction 
such that high values exemplify freely diffusing water and reduced microstructural 
integrity. For example, MD is elevated in WMH (189). Counter to MD, fractional 
anisotropy (FA) is indicative of the degree of anisotropic water diffusion ranging on a 
scale of 0-1 with 0 representing random diffusion and 1 representing completely 
directional diffusion (173, 188). Healthy WM FA values typically fall above 0.35, 
while in damaged WM values dip below 0.3. More descriptive still, are the radial 
diffusivity (Dr), and axial diffusivity (Da) measures that can ascribe specificity to WM 
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damage. Animal models have revealed demyelination is related to increased Dr 
whereas axonal damage or loss may occur with increased Da (121, 274, 275, 282, 298). 
CLINICAL IMPORTANCE 
  As foci of damage to WM, the clinical implications of WMH will be 
discussed rather than DTI metrics. The clinical importance of WMH has long been 
debated, but there is mounting evidence that WMH is related to cognitive dysfunction 
and rate of cognitive decline (19, 40, 307). It is possible that WMH mediates the 
relation of cardiovascular risk factors and vascular dysfunction to cognitive 
dysfunction. The role of modifiable cardiovascular risk factors in relation to WMH and 
cognitive function will be discussed in greater detail in subsequent sections.  
Regardless of the cause, many studies have outlined associations between WMH and 
cognitive function.  In particular, WMH appears to retard executive functioning tasks 
as well as memory in older adults (213). Some memory tasks appear more related to 
WMH than others. For example, the Digit Span is consistently unrelated to either deep 
or periventricular WMH, yet other working memory tasks are significantly related to 
WMH (214). The relation of cognitive function to WMH may have best been 
summarized in a quantitative review that found global functioning, speed tasks, 
immediate memory, delayed memory, and executive function were all significantly 
associated with WMH scores (108). 
  Given the relationship between WMH and cognitive dysfunction, it is not 
surprising that WMH is related to cognitive disease. A large longitudinal study with an 
average follow-up of 7.3 years showed an accelerated decline of global cognition on 
the Mini-Mental State Exam with increasing severity of WMH after controlling for 
  76 
numerous covariates (61).  This increased rate of cognitive decline appears to carry 
into the development of dementia.  One study demonstrated a 1.6 fold increased risk of 
developing dementia for every standard deviation increase of WMH severity 
independent of other possible disease contributors including age, sex, education, 
hypertension, diabetes, smoking, and apolipoprotein E (APOE) 4 genotype (233). Both 
of these findings are supported by a systemic review and meta-analysis suggesting that 
WMH are associated with a 1.9 fold increased risk of dementia and hastened decreases 
in global cognition, executive function, and processing speed (69). The inclusion of 
confounding influences in the statistical analyses of these studies suggests the 
independence of WMH in its relation to negative outcomes and may indicate the WM 
damage may be irreversible.  
Dementia Risk Factors  
NON-MODIFIABLE RISK FACTORS 
  Some risk factors for cognitive decline and dementia are non-modifiable 
while others can be manipulated through behavioral or pharmacological interventions. 
Age is an unwavering, non-modifiable risk factor for cognitive decline, WMH, and 
dementia (67, 333). While family history does not definitively predetermine the 
development of dementia, it is another formidable, non-modifiable risk factor that 
varies across race (104). Having a first-degree relative with dementia increases AD 
risk by about 39% and having more than one first-degree relative increases risk even 
further (171). Heritability of dementia risk factors is another non-modifiable 
phenomenon. Inheritance of one APOE4 allele increases the risk of AD by about three 
times, while inheriting two copies increases the risk 8-12 fold (133, 182).  APOE4 
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carriers tend to exhibit increased WM vulnerability compared with non-carriers (129). 
In young adults (20-35 years), older adults (50-78 years), or when pooled, APOE4 
carriers showed decreased FA compared with non-carriers. In older adults, MD was 
significantly elevated in APOE4 carriers compared with non-carriers. This finding 
suggests that APOE4 exerts a negative effect on cerebral WM irrespective of age. 
Other genetic risk factors include the passing of duplications or mutations of amyloid 
precursor protein, presenelin 1, and presenelin 2 genes (182).  Nonetheless, APOE4 is 
the most commonly recognized genetic risk factor for AD. Little can be done to 
assuage the neurocognitive damages conferred from these non-modifiable risk factors. 
However, modifiable cardiovascular risk factors are significant contributors to vascular 
dysfunction, deterioration of WM, and ultimately dementia can be positively 
influenced.  
MODIFIABLE RISK FACTORS 
Adiposity 
  Adipocytokines.  Excess adipose tissue is not a benign, inert, harmless 
byproduct of weight gain and obesity. On the contrary, excess adipose tissue is 
hormonally active and constitutes the largest endocrine organ in the body (322).  
Adipocytes are larger in size in obese individuals and produce proinflammatory 
proteins known as adipocytokines (232).  Visceral adiposity, adipose tissue 
surrounding internal organs, may secrete more adipocytokines than subcutaneous fat 
(13). These cytokines include, but are not limited to, interleukin-1 (IL-1), interleukin-6 
(IL-6), tumor necrosis factor-α (TNF-α), leptin, and adiponectin (44).  Pro-
inflammatory cytokines including C-reactive protein (CRP) and TNF- α are elevated in 
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the obese phenotype (105, 152). Such inflammatory factors are associated with 
vascular dysfunction and promote blood brain barrier disturbances, thus contributing to 
dementia.  These associations were demonstrated in a 25-year follow-up study of 
middle-aged adults, participants above the first quartile of CRP exhibited a 3-fold 
increased risk of acquiring vascular dementia or AD (251).   
  Hormones such as leptin and adiponectin can also advance dementia 
pathology. Leptin usually combats adiposity by increasing metabolism and appetite. 
However, individuals with obesity may lose sensitivity to leptin thereby stimulating 
overproduction and elevated levels of the metabolic hormone (123). Leptin has been 
associated with accumulation of amyloid-β related to AD, and elevated levels of leptin 
are correlated to poor cognitive function in elderly women (85, 336).  Adiponectin is 
the most secreted adipocytokine and serves multiple roles including fatty acid 
metabolism, anti-inflammation, and, importantly, aiding in the maintenance of glucose 
homeostasis through enhancing insulin sensitivity and reducing liver gluconeogenesis 
(183, 273).  Withdrawn control of these functions from reduced adiponectin production 
or sensitivity has detrimental effects on the brain. Impaired cognitive functioning has 
been associated with lower adiponectin, but not with further cognitive decline or 
advancement to Alzheimer’s disease (292).  Despite this evidence, investigations of 
leptin and adiponectin in relation to dementia are sparse. Since these damaging 
proteins largely originate from visceral adipose tissue accurate anthropometric 
measurement of visceral adiposity for large studies is of critical importance. Honing 
the most reliable anthropometric assessments reflective of visceral adipose tissue will 
strengthen our ability to accurately evaluate the relations of adiposity and the brain. 
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  Adiposity Measurement. As of 2015, 69% of adults in the U.S. were 
classified as overweight and 34% classified as obese (200). This alarming prevalence 
is a significant public health concern as adiposity is negatively related to WM health 
and cognitive function and positively to dementia at midlife (74, 115, 278). Adding to 
the difficulties in this area of research are the many ways in which adiposity is 
assessed.  While anthropometric measures were developed for their ability to represent 
underlying adiposity, each vary in their specificity. Body mass index (BMI) is 
calculated by mass in kilograms divided by height in meters squared (kg/m2). BMI is 
epidemiologically valuable because of its ease of use.  However, this blunt metric is 
not necessarily indicative of adiposity (57). Waist-to-hip ratio (WHR) divides waist 
girth by hip girth and has solid predictive power for cardiovascular disease events 
(238).  Using this ratio may be less viable for cross-sectional studies due to sex 
differences in adipose deposition despite sex specific cutoffs implemented to reduce 
such concern. Waist circumference (WC) is strongly related to visceral adiposity. 
Neither WHR nor WC effectively characterizes subcutaneous fat (230). Other methods 
to estimate body fat include simple anthropometry of hip circumference and waist to 
thigh ratio, as well as more complex procedures of skinfolds, air plethysmography, and 
underwater weighing.  Dual energy x-ray absorptiometry (DXA) can sensitively 
quantify whole body, subcutaneous, and visceral adipose tissue mass and volume. 
While DXA is a valuable tool in clinical settings, anthropometric measures of 
adiposity are more useful for large-scale population based studies.   
  Ascertaining adiposity indices most indicative of WM health and cognition in 
a controlled setting is a necessity.  Despite the multitude of methods for assessment, 
those most indicative of underlying adiposity and sensitive to composition are best 
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suited as indicators of cerebral health. While studies investigating the relation of 
anthropometric measurements of adiposity and brain healthy are common, their 
comparative value as indicators of white matter health at midlife is missing. This 
omission in the literature is undoubtedly in need of addressing. Nonetheless, previous 
studies have used a variety of methods to determine the relationship between adiposity, 
brain structure, and cognitive function.  
  White Matter Integrity. In relation to WM integrity, BMI is negatively 
associated with FA of multiple WM tracts, including the corpus callosum, fornix, 
cingulum, and corona radiata (166). These tracts aide in the integration of temporal and 
frontal regions typically associated with facilitating executive functioning and 
memory. WMH are also associated with increased BMI in older adults and elderly 
cohorts in some, but not all, studies (116, 119, 146).  The relationship of BMI and 
WMH has also been observed at midlife (216).  With prevalent reports of relations of 
WM with cognitive function, and obesity, increased risk of dementia with greater BMI 
is logical. Indeed, individuals with obesity at midlife were found to be twice as likely 
to acquire dementia 18 years later (160). Therefore, it stands to reason that obesity can 
negatively affect executive function and memory with advancing age.  
  Cognitive Function. The relationship of adiposity and cognition across the 
lifespan remains a controversial topic. Obesity appears to impair cognitive function 
from an early age through adolescence (4-19 years), with evidence indicating poorer 
cognitive function in obese individuals compared to those of normal weight (110, 179, 
277). At midlife, the same relationship exists, with most cross-sectional studies finding 
a negative association between BMI and cognitive function (109, 110, 206).  This 
linear relationship may veer off course in the elderly as obesity has shown to be 
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positively associated with cognitive function in septuagenarians (167). It has been 
hypothesized that individuals who are obese throughout the lifespan experience a 
steeper decline in weight during old age (113). This trajectory is contrasted with 
individuals of normal weight whose weight decline is more gradual. Taken together, 
this theory explains the divergent, non-linear relationship between adiposity and 
cognitive function.   Individuals with a higher BMI at midlife, but underweight in old 
age exhibited poorer survival from dementia after seven years of follow-up (86). 
Regardless of age demographic, in instances of lower cognitive functioning, executive 
function is the domain most frequently affected (267). Despite the non-linear 
relationship of adiposity and cognition across the lifespan that may be moderated by 
obesity, midlife obesity is associated with increased risk of dementia, as evidenced 
with prospective studies (86, 236, 323). Compounding this increased risk are other 
cardiovascular comorbidities at midlife including metabolic syndrome (MetS) 
components that are independently associated with heightened risk of dementia (160). 
Metabolic Syndrome 
  Components and Prevalence. Modifiable cardiovascular risk factors are 
often accumulated comorbidly throughout the lifespan.  When a cluster of three risk 
factors of abdominal obesity, dyslipidemia, elevated blood pressure, and 
hyperglycemia occurs in a single individual, it is ascribed as metabolic syndrome 
(MetS) (10).  These risk factors are highly prevalent in the U.S. Currently, 69% of 
adults in the U.S. are overweight, while 43% have hypercholesterolemia, 33% have 
hypertension, and 9% have diabetes (200).  The prevalence of MetS in the U.S. was 
estimated to be 34.7% in 2011-2012 (6).  
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  Specific cutoffs for MetS components are largely agreed upon, though there 
is some variability for impaired fasting glucose and abdominal obesity due to 
population differences between ethnicities. Nonetheless, in the U.S., the abdominal 
obesity criteria for MetS is denoted by waist circumference (≥94 cm for men and ≥80 
cm for women); elevated triglycerides (≥150 mg/dL); reduced HDL cholesterol (<40 
mg/dL for men and <50 mg/dL for women); increased blood pressure (systolic blood 
pressure ≥130mmHg and/or diastolic blood pressure ≥85mmHg); elevated fasting 
glucose (≥100 mg/dL); pharmacological intervention for any condition above.  The 
National Heart, Lung, and Blood Institute and World Health Organization established 
these criteria (2, 10).  Whether they exist in isolation or together in an individual, MetS 
components can contribute to maligned WM and cognition. 
  White Matter Integrity. Investigations of MetS and WM are limited with few 
assessing cerebral microstructure. Nonetheless, individuals with increasing vascular 
risk factors showed incrementally reduced FA (185). Separately, a sample of older 
adults with MetS displayed significantly reduced WM integrity in the frontal lobe 
bilaterally compared with healthy controls (261). These MetS subjects who had lower 
FA in anterior regions further displayed poorer performance on executive function 
speed tasks (260). The anterior to posterior gradient of damaged WM is a recognized 
pattern in normal aging (158). Because WM damage acquired by individuals with 
MetS presents in a similar pattern, it may reflect an accelerated aging phenotype.  
  Cognitive Function. Anterior brain regions are tasked with the performance 
of executive function. Within the executive function domain are duties essential to the 
performance of everyday tasks including decision-making, judgment, attention, and 
problem solving. This functional relationship may explain previous observations of 
  83 
reduced executive function in older individuals with MetS, as frontal regions may be 
more vulnerable to vascular insults (36, 46, 252).  WM integrity in individuals with 
MetS has also been associated with hindered performance on recall and memory tests 
(124, 163, 201).  However, these findings are not all in agreement.  MetS has been 
shown to affect different domains of cognitive function. Although results are 
sometimes inconsistent across gender, some cross-sectional studies showed MetS 
having no associations with any domain of cognitive function (118, 332).  These 
differential findings may be explained through sampling differences between studies in 
relation to age, neurocognitive assessment differences, or risk factor exposure duration. 
Despite these differences, MetS has been associated with impaired verbal memory, 
fluid intelligence, and psychomotor speed as well as executive function in large and 
case control cross-sectional studies (46, 59, 259, 303). Longitudinal investigations 
support these results showing that MetS is related to impaired global cognition, verbal 
fluency, and psychomotor speed independent of age, sex, and education (161, 328).  
  Dementia. Decrements of cognition in relation to MetS seem to result in 
increased risk of dementia.  Cross-sectional and prospective studies have found 
deleterious effects of MetS on cognitive function and increased risk of dementia (59). 
Investigators have reported increased risk of cognitive impairment, vascular dementia, 
and Alzheimer’s disease in both cross-sectional and longitudinal studies (235, 237, 
271, 306). However, one prospective study was unable to find a link between MetS 
and risk of dementia in the elderly 65 years and older, while another showed a 
decelerated cognitive decline in elderly adults 85 years and older in relation to MetS 
(201, 302).  
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  Damage mechanisms. The mechanisms by which MetS components cause 
damage to the brain have yet to be fully described, but undoubtedly, MetS increases 
risk for cardiovascular disease and dementia several fold (187, 235).  Whether MetS 
components confer WM damage individually or synergistically remains to be 
elucidated. Furthermore, individuals with MetS have impaired endothelial function that 
could limit cerebrovascular reactivity and cerebral activation in relation to memory 
tasks (87, 100, 172). The pro-inflammatory state that exists with MetS may also 
exacerbate vascular dysfunction while damaging the BBB (77, 308). What has been 
shown is MetS contributes to arterial stiffening that leads to cerebral WM damage 
(248, 255). 
Arterial Stiffness  
  Characteristics and Mechanisms. Arterial stiffness is a hallmark of vascular 
aging that develops from structural and function changes. Vascular stiffening is non-
uniform in the arterial tree affecting central and conduit arteries more than peripheral 
and muscular arteries (32). Continuously heightened intravascular pressure as seen in 
hypertension can result in structural remodeling of the blood vessel. This remodeling is 
characterized by loss of flexible elastin protein and over-production of collagen (327).  
The mechanical stress of elevated pressure combined with increased inflammatory 
substances promotes excessive collagen production (149, 327). In addition to these 
histological changes, the surrounding smooth muscle layer hypertrophies, further 
contributing to arterial stiffening (310).  
  Separate from structural alterations, functional changes influence arterial 
stiffness. Hormones, salt, and glucose regulation among other vasoactive factors can 
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influence the degree of arterial stiffness (340).  Vascular smooth muscle tone can be 
modified by mechanical influences and endothelial cell signaling via vasoactive 
substances.  In the stiffened artery, endothelial dysfunction is characterized by 
mismatched reactivity to acetylcholine conferred through disparate nitric oxide (NO), 
endothelial-derived hyperpolarizing factor, and constrictor hormones (195).  The 
presence of vasoconstrictors angiotensin and endothelin as well as oxidant stress 
increases fibrosis and vascular smooth muscle cell hypertrophy (340).  In contrast, 
production of NO can reduce macrophage infiltration and help preserve vascular 
function and arterial elasticity. However, endogenous nitric oxide synthase inhibitor 
asymmetrical dimethylarginine, reactive oxygen species such as peroxynitrite, and 
advanced glycosylated end products collectively diminish vascular NO bioavailability 
(198, 284).  Excessive dietary salt intake is also harmful to the vasculature. Vascular 
smooth muscle tone is heightened in response to salt. Furthermore, salt prompts 
vascular smooth muscle cell hypertrophy and proliferation of collagen and elastin (107, 
218, 243). Lastly, sodium increases asymmetrical dimethylarginine thereby impeding 
NO production and impairing endothelial function (22).  
  The causal directionality between arterial stiffening and endothelial 
dysfunction has not been established, as both often coexist. Rather, the two may 
negatively influence each other cyclically. Major conduit arteries such as the aorta and 
carotid arteries are most subjected to stiffening, resulting in impaired ability to buffer 
pulsatile flow from the heart (95, 340). Loss of this function results in the transfer of 
pulsatility to resistance vessels less capable of accommodating pulsatile stress. Arterial 
stiffening is observed in many disease states, including aging, hypertension, diabetes, 
and MetS (89, 107, 248, 337). 
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  Influence of Sympathetic Nerve Activity. Sympathetic nerve activity (SNA) 
is associated with total peripheral resistance and is an indicator of vasoconstrictor tone 
(50). SNA serves an integrative role in the regulation of blood pressure, heart function, 
and arterial stiffness through direct and indirect mechanisms. Arterial baroreceptors are 
charged with detecting acute changes in blood pressure. In the event of hypotension or 
unloading of these receptors, the arterial baroreceptors signal the nucleus tractus 
solitarius that communicates with the rostral ventrolateral medulla (RVLM) to increase 
SNA and restore adequate pressure. This is accomplished through the release of 
acetylcholine that prompts secretion of neurotransmitters norepinephrine, epinephrine 
and isoprenaline from neurons and the adrenal medulla, that have a number of actions 
dependent on receptor type and location. At the heart, β1 receptors increase heart rate 
and left ventricular contractility that results in increased stroke volume and together 
increase cardiac output (343). At the vasculature, binding of norepinephrine and 
epinephrine at α1 receptors leads to increased intracellular calcium that promotes 
vasoconstriction from contraction of smooth muscle cells and increased vascular tone 
(226). Altogether, activation of this sympathetic network can cause acute increases in 
arterial stiffness (217). If chronically activated, the arterial baroreflex can become reset 
to a greater set point that is linked to greater SNA leading to hypertension and arterial 
stiffening (49). Although, the causal direction of these events has not been fully 
elucidated. 
  SNA and arterial stiffness can be further induced via the renin angiotensin 
aldosterone system (RAAS). Principally, the RAAS is designed to ensure appropriate 
perfusion pressure to the kidneys so that blood can be adequately filtered of toxins. 
When flow decreases to the glomerulus, juxtaglomerular cells release renin that 
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converts angiotensinogen to angiotensin 1 which is then converted to angiotensin 2 by 
angiotensin converting enzyme.  Angiotensin 2 has numerous effects on the 
vasculature. Specifically, angiotensin 2 increases SNA, absorption of sodium that 
allows for water retention, and signals aldosterone secretion from the adrenal glands 
that furthers sodium reabsorption (222).  Additionally, angiotensin 2 prompts secretion 
of antidiuretic hormone form the pituitary gland to aid in water retention. Each of these 
angiotensin 2 actions aid in the restoration of necessary perfusion pressure to the 
kidneys. However, dysregulation of this system could result in chronically elevated 
SNA, hypertension, and corresponding vascular stiffening. 
  Cardiovascular risk factors have also been associated with overactive SNA.  
In individuals with essential hypertension, muscle SNA is elevated to a degree 
corresponding with severity (331). While this elevation may come about through 
chronic excess sodium intake or resetting of the arterial baroreflex, individuals with 
hypertension tend to exhibit a heightened sensitivity to hypoxia and carbon dioxide 
resulting in an overactive chemoreflex (272). Overactive SNA can be further 
exacerbated by excessive adipose tissue that can secondarily perpetuate hypertension.  
Obese individuals with excess adipose tissue exhibit SNA over activation that is 
directly associated with visceral adipose tissue (14). Mechanistically, this may exist 
because neurotransmitters associated with SNA such as isoprenaline, norepinephrine 
and epinephrine can act on β3 receptors located on brown adipose tissue that increase 
lipolysis and thermogenesis via increases in cyclic adenosine monophosphate (215). 
Although this mechanism aims to reduce excess fat, the corresponding increase in 
SNA likely also increases the tone of the vascular smooth muscle making obese 
individuals more susceptible to the development of hypertension. Chronically elevated 
  88 
blood pressure in turn can prompt remodeling of the vascular scaffolding proteins 
characterized by greater collagen and reduced elastin expression that is commonly 
observed in the pathogenesis of arterial stiffening. On top of obesity and hypertension, 
hyperinsulinemia potentially leads to elevated SNA. Indeed, individuals who are 
insulin resistant demonstrate elevated resting heart rate and SNA when compared with 
healthy controls (16, 84).  
  Sex Differences. Sympathetic control of blood pressure appears to diverge 
between men and women. In healthy young men and women, SNA was unrelated to 
mean arterial pressure (122). The absence of this relationship highlights the high level 
of interindividual variability of SNA as well as the fact that there are myriad inputs 
governing blood pressure control. Young men and women display differences in the 
relationship of SNA and cardiac output in that the relationship was absent in young 
women, while SNA was significantly inversely associated with stroke volume in young 
men (122). Women also have shown greater increases in heart rate with a lesser change 
in total peripheral resistance compared with men when taxed with an orthostatic 
challenge (71, 91).  This finding suggests sex differences in baroreflex sensitivity. This 
divergence in physiological response to blood pressure challenges may be explained by 
differences in catecholamine production between sexes. In rats, estrogen may have an 
attenuating effect on catecholamine production, however, sex differences in 
catecholamine production and responses in humans remain equivocal (83, 343).  
  Estrogen in premenopausal women has significant effects on the vasculature 
and consequently SNA control of blood pressure. Estrogen stimulates the release of 
vasoactive molecules such as nitric oxide that potentiate vasorelaxation as evidenced 
by increased endothelium-dependent vasodilation (204). Estrogen likely also 
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influences vascular tone through effecting calcium channels either through attenuated 
release, influx or increased efflux of calcium (321). Interactions with high-density 
lipoprotein that lead to reduced oxidation of low-density lipoprotein demonstrate 
estrogen’s potential anti-oxidant and anti-inflammatory properties (321). This 
combination of effects on the vasculature can mitigate atherosclerosis and 
consequently arteriosclerosis with aging. 
  With age, both men and women experience increased SNA. When compared 
with young men, premenopausal women tend to have reduced SNA until after 
menopause, when estrogen is significantly attenuated, SNA sharply increases (192). 
Differences in SNA are important to investigations of arterial stiffening as it has 
recently been associated with carotid arterial compliance in young and old men (287).  
It is possible that this relationship is absent in young women due to the presence of 
estrogen and may begin post menopause, however, this has never been investigated. 
  Assessment. Assessing the stiffness of arteries can be accomplished in many 
ways depending on the blood vessel being measured. In relation to cardiovascular 
disease, arterial stiffness of major central blood vessels is indicative of coronary heart 
disease and stroke (193). This relationship is demonstrated in the assessment of aortic 
stiffness with carotid to femoral pulse wave velocity (cfPWV). With this method, 
applanation tonometery of the carotid and femoral arteries can track the transit time of 
the forward traveling pulse wave between the two sites. The straight distance between 
the two sites when divided by the transit time from foot to foot of the wave form 
calculates the rate of the pulse wave, which is indicative of the stiffness of the blood 
vessel (239).  
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  Because of the high cost of arterial tonometers necessary to measure cfPWV, 
a more simple measure involving only the inflation and deflation of blood pressure 
cuffs at the four extremities was developed. With this method, brachial-ankle pulse 
wave velocity (baPWV) can be determined; yielding qualitatively similar information 
as cfPWV that also includes the periphery in its determination of arterial stiffness 
(281). Although neither cfPWV nor baPWV has been identified as a significant 
predictor of dementia, they are both significantly associated with cognitive 
impairment, WMH, cerebral microbleeds, and cerebral infarcts in middle-aged and 
older cohorts (305).  Additionally, pulse wave velocity is related to increased amyloid-
beta deposition in the brain in the very elderly, suggesting that the two may be related 
in the development of dementia (136).  
  Compared with the central aorta, the carotid artery is closer to the cerebral 
circulation, providing blood flow to the middle cerebral arteries. Measurement of the 
stiffening of the carotid artery is accomplished with the coupling of B-mode ultrasound 
and arterial tonometry. When paired together, indices of arterial elasticity and stiffness 
can be calculated. Carotid artery compliance (CAC) is calculated as the absolute 
change in vessel diameter for a given pressure step. Distensibility is the relative change 
in vessel diameter for a given pressure step. Because these indices are heavily related 
to blood pressure, beta-stiffness index is often calculated to correct for distending 
pressure (209). Together, these previously discussed methods serve as comprehensive 
markers of arterial stiffness for major blood vessels. 
  Metabolic Syndrome. MetS components each insidiously affect arterial 
stiffness. As mentioned above, excessive adiposity is highly associated with increased 
inflammation that is damaging to the endothelium and NO production.  Individuals 
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with heightened adiposity could also have elevated circulating triglycerides or reduced 
presence of anti-atherogenic molecule high-density lipoprotein (HDL). Reduced HDL 
is independently associated with increased aortic PWV (240). MetS is correlated with 
stiffening of the vasculature, and it is likely that central adiposity and elevated blood 
pressure are key contributors to this relation (70). Specifically, abdominal obesity 
measured through waist circumference or visceral adiposity as measured through 
DEXA is significantly related to cfPWV and baPWV (280). General adiposity, often 
characterized by BMI, is not related to aortic stiffness at midlife (248). It appears that 
MetS accelerates the age-associated increase in arterial stiffening throughout the 
lifespan (254). This finding is concerning considering dementia is an age-related 
disease exacerbated by arterial stiffening. Taken together, these notions suggest that 
MetS could raise the risk of dementia through an arterial stiffening mechanism. 
Neural Consequences. Arterial stiffening regardless of etiology has marked effects on 
brain structure and cognitive function. Further, transmission of pulsatile forces from 
stiffened proximal central blood vessels elicits damage to cerebral microvessels ill 
equipped to handle pulsatile stress (197).  Additionally, loss of Windkessel function, 
the ability of vessels to cushion pulsatility from the heart, as a result of arterial 
stiffening can disrupt consistent perfusion to end organs, including the heart and brain 
(31).  The chronic mechanical stress of elevated pulsatile flow prompts structural 
changes in cerebral arterioles in an attempt to protect vulnerable cerebral capillaries.   
  From a structural perspective, smooth muscle hypertrophy often observed 
with arterial stiffening occurs at the expense of the vessel lumen diameter (144).  
Consequently, greater vascular resistance and reduced cerebral blood flow can occur 
(38).  Compounding the detrimental effects of increased resistance, these structural 
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adaptations impair cerebral arteriole endothelial function, thus partially impairing 
functional hyperemia (27).  The protrusion of pulse pressure into cerebral arterioles 
can damage the blood brain barrier, leading to a cyclic inflammatory cascade (196, 
208). The cumulative effects of arterial stiffening damage the grey and white matter 
parenchyma through attenuated perfusion. Demonstrating this oligemic effect are 
associations of arterial stiffness with reduced deep subcortical grey and WM perfusion 
(289, 290).   
  White Matter. Reduced cerebral perfusion suggests a possible mechanistic 
explanation for the 13 cross-sectional investigations highlighted in a review observing 
the associations between arterial stiffness measures and WMH or lacunar infarctions 
(264). All but four of these investigations were in older populations.  Only two 
longitudinal studies assessed the relationship between arterial stiffness and WMH 
tracking individuals at midlife for 7 years and older adults for 10 years (159, 241). 
Both studies identified arterial stiffness as an independent predictor of WMH volume. 
Pulsatility corresponding with arterial stiffness is further associated with lower whole 
brain, grey matter, and WM volumes (197).   
  Despite these results, probes of the relationship between arterial stiffening 
and WM integrity, particularly at midlife, are remarkably few. In healthy older adults 
and those with mild cognitive impairment, arterial stiffness is associated with reduced 
global FA (288). An epidemiological study supporting this finding observed reduced 
FA in the corpus callosum and increased arterial stiffness in a middle-aged community 
sample (186). The paucity of research in middle-aged cohorts needs correction as DTI 
indices of WM integrity can reveal early damage to the cerebral WM in relation to 
cardiovascular targets. 
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  In relation to cognition, arterial stiffening exerts a consistently negative effect 
on executive function.  In a prospective study of older adults, arterial stiffness was 
significantly associated with poorer performance on an executive function task (228).  
Cross-sectional investigations of middle-aged and older adults support this finding (78, 
289). Memory, global cognition, and other cognitive tasks are also negatively affected 
by arterial stiffening in older adult and elderly cohorts (257, 258, 297, 318).  Despite 
these associations, the link of arterial stiffness to cognitive decline and dementia has 
yet to be examined prospectively (228). Nonetheless, cross-sectional and longitudinal 
evidence asserts a robust relationship between arterial stiffening with brain structure 
and cognitive function. Less precisely defined, is this relationship at midlife. 
Observing more sensitive measures of early changes to the WM and an intensive 
cognitive battery in relation to stiffening of the carotid artery may bring to light the 
early deleterious nature of arterial stiffness. The carotid artery is of particular interest 
because it is closer to the cerebral circulation than the aorta and is often the subject of 
arterial stiffening.  
Physical Activity  
VASCULAR RISK FACTORS 
  The effects of physical activity, in particular aerobic exercise, on 
cardiovascular risk factors and arterial stiffness are well documented. Chronic aerobic 
exercise is a valuable strategy to attenuate vascular risk factors. Aside from reducing 
caloric intake to achieve caloric deficit, physical activity is an efficacious intervention 
to lose adipose weight (73). In a large cross-sectional study of middle-aged men, 
physical activity performed commuting to employment and practicing high-intensity 
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recreational activities was negatively associated with BMI, waist circumference, and 
body weight (315).  Reduced adiposity through physical activity may reduce 
corresponding low chronic inflammation in parallel.  Indeed, men and women aged 40 
and older who frequently perform physical activity have significantly lower markers of 
c-reactive protein, white blood cell count, and fibrinogen (5). In older Chinese adults, 
total physical activity was associated with reduced C-reactive protein levels and odds 
of acquiring MetS (335). In this same study, quartiles of inflammatory profile and 
adipocytokine z-scores are also related to increased odds of MetS regardless of 
physical activity tertile. Taken together, these data suggest that physical activity can 
improve adiposity, inflammation. 
  Aerobic exercise, defined as physical activity intentionally performed for 
health benefits through elevated heart rate and oxygen consumption, positively affects 
components of MetS beyond adiposity. In a cohort of 30-40 year old men and women 
with reduced HDL and high triglycerides, an aerobic exercise intervention for 20-
weeks with increasing duration and/or intensity caused a significant increase in HDL, 
reduction in triglycerides, and an overall decrease in total cholesterol (58). Systolic and 
diastolic blood pressure also reduced following dynamic exercise training of at least 4-
weeks. A meta-analysis of 14 studies showed a 3 and 2 mmHg reduction of systolic 
and diastolic pressure, respectively, in normotensive adults; whereas individuals with 
hypertension exhibited greater reductions of 7 and 6 mmHg (79). Lastly, physical 
activity is related to insulin sensitivity. This relation was demonstrated in a cross-
sectional study of men and women aged 30-60 years that found total physical activity 
time was significantly associated with insulin sensitivity (23). Simply performing 2.5 
hours of walking per week was related to a 60-70% reduced risk of acquiring diabetes 
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after an average four years of follow-up in middle-aged adults (168). The cumulative 
effects of physical activity on MetS components appear largely positive. Chronic 
physical activity and aerobic exercise can also ameliorate arterial stiffening associated 
with metabolic components.  
ARTERIAL STIFFNESS 
  In general, performance of physical activity for health purposes is affordable, 
easily accessible, and safe for middle-aged and older adults who need to ameliorate 
arterial stiffening. Physical activity and chronic aerobic exercise are well-documented 
robust lifestyle interventions capable of improving arterial stiffness irrespective of age 
or sex (151, 285, 286). This relationship has been demonstrated across a number of 
indices of arterial stiffening. These same interventions can ameliorate components of 
MetS related to the stiffening of arteries (58, 79, 176, 177, 280). Beneficial vascular 
adaptations to chronic aerobic exercise, and ostensibly moderate to vigorous physical 
activity, are accomplished through a combination of structural and functional changes.  
In stiffened vessels, where collagen is overexpressed and elastin is diminished, the 
cross-linking of stiff collagen fibers may be stretched leading to greater overall vessel 
flexibility. Functionally, chronic shear stress caused by physical activity and exercise 
can stimulate the production of vasoactive factors such as nitric oxide. Using different 
macro- and microvascular function assessments, including flow-mediated dilation, 
acetylcholine infusion, and others, endothelial dependent vasodilation tends to be 
improved following exercise interventions (103). Increased NO bioavailability in the 
central blood vessels could lead to reduced arterial stiffening. Reductions in 
inflammation and reactive oxygen species from up-regulated superoxide dismutase 
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occur with chronic physical activity (92). These changes lead to decreased scavenging 
of NO. These vascular adaptions to physical activity are valuable from a clinical 
perspective as physical activity and aerobic exercise may be used to combat 
neurocognitive disease of vascular etiology. To date, an insufficient number of studies 
have examined the role of physical activity behavior in improving both arterial 
stiffness and brain structure, specifically the WM.   
WHITE MATTER INTEGRITY  
  Current research supports the view that physical activity positively affects the 
cerebral white matter. The observed white matter benefits of physical activity could be 
crucial in the avoidance of unhealthy cognitive aging.  While physical activity may not 
impact global WMI, positive associations between regional white matter regions have 
been observed cross-sectionally. In young and old adults, estimations of aerobic fitness 
showed significant associations with the cingulum and uncinate fasciculus independent 
of age or sex (191). The same investigators observed peak oxygen consumption to be 
moderately related to increasing FA in the left middle cingulum (190).  Additionally, 
two separate large cross-sectional cohorts of older adults demonstrated self-reported 
physical activity to be related to WMI in a multitude of white matter regions (98, 102).  
Intervention studies support these findings. A progressive 6-month aerobic exercise 
intervention was compared with a stretching control group investigating white and 
grey matter volumes in cognitively normal older men and women. After the 
intervention, white and grey matter volumes increased in frontal and temporal cortices 
(55).  Separately, a one-year walking intervention was capable of improving both 
aerobic fitness and WMI.  Here, changes in aerobic fitness were significantly 
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associated with changes in frontal, parietal, temporal, and occipital white matter FA 
(313). Changes in aerobic fitness were also related to improved short-term memory in 
the walking group. Using fitness to support WMI is a valuable strategy to preserve 
cognitive function, as age-related decrements in decision related task performance are 
mediated by changes in WMI (184). Considering deterioration of cerebral white matter 
exists with aging and is accelerated in dementias, its preservation through physical 
activity could be an integral strategy to prolonging healthy cognitive function.   
COGNITIVE FUNCTION 
  Consistent with structural improvements in the brain stemming from physical 
activity, similar benefits are observed in cognitive function. Impairments in executive 
function are most often related to aging and vascular dementia.  Aerobic exercise 
interventions and the chronic performance of moderate-vigorous physical activity can 
impact multiple domains of cognition, but executive function appears most affected. 
Cross-sectional evidence from 24-76 year olds, showed that aerobic fitness was 
significantly associated with executive function tasks after accounting for age, sex, and 
intelligence (301). Prospectively, baseline cardiorespiratory fitness is significantly 
associated with protection of global cognitive function, attention, and executive 
function, as well as memory and verbal fluency (25).   Exercise intervention studies 
support this observation. In older adults aged 55-70 years, four-months of aerobic 
exercise training resulted in improved performance on a number of neuropsychological 
tests, including significantly improved executive function and reaction time among 
others (75). Additionally, sedentary older adults exposed to a one-year aerobic 
exercise-training program were more resistant to decreases in cognitive performance 
  98 
on a logical memory subtest than those who remained sedentary (132). This evidence 
demonstrates the importance of maintaining or developing aerobic fitness for cognitive 
benefits. 
  In relation to risk of dementia, physical activity seems to offer a strong 
protective effect. Time and again, prospective evidence of elderly individuals (>65 
years) yields significant associations between physical activity and reduced risk of 
cognitive decline. These findings are consistent with performance of either moderate or 
vigorous physical activity (270).  With respect to frequency, three exercise sessions or 
more every week resulted in a significantly lower hazard ratio of developing incident 
dementia compared with inactive participants during follow-up after controlling for 
age and sex (169). Finally, a 5-year longitudinal study showed a dose-response 
relationship with levels of physical activity and protection from developing 
Alzheimer’s disease among women (170). These intervention and observational 
evidences demonstrate that performing physical activity and improving aerobic fitness 
are viable strategies to prevent cognitive decline and prevent dementia. 
  While these studies encourage the use of physical activity and aerobic 
exercise to prevent further cognitive decline and development of dementia, the efficacy 
of PA to improve cognition in individuals already exhibiting signs of cognitive 
impairment must be considered. An excellent synthesis of this work was performed 
and analyzed the effects of different exercise modes on physical and cognitive function 
in subjects 65 years or older with baseline Mini-Mental Status Examination scores of 
less than 26 (130). This meta-analysis revealed that exercise interventions of aerobic 
training, resistance training, or stretching had significant medium-large effect sizes on 
physical fitness outcomes, as well as cognitive outcomes. This study asserts that 
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despite already being cognitively impaired, older adults can participate in regular 
physical activity and improve diminished cognitive function.  
MECHANISMS 
  How physical activity benefits successful cognitive aging remains to be fully 
understood. However, there are a number of potential mechanisms explaining the 
therapeutic and disease preventing properties of physical activity. With exercise, a 
number of neurobiological adaptations in the brain occur.  Animal studies suggest that 
aerobic exercise in aged rats leads to proliferation of neurons in the dentate gyrus, 
increased mRNA expression for excitatory neurotransmitter receptor N-methyl-D-
aspartate in the dentate, and up-regulated brain derived neurotropic factor mRNA 
levels in the hippocampus (81, 93, 304).  Insulin-like growth factor-1 (IGF-1), a 
molecule critical for neurogenesis and mediating neuronal activity, levels is amplified 
with chronic exercise (45, 296).  The neural effects of IGF-1 may also explain why 
greater effect sizes were observed in studies examining combined strength and aerobic 
exercise interventions in relation cognitive function (54). Increased vascular 
endothelial growth factor (VEGF) has also been seen with exercise in old rats (72). 
VEGF is a critical molecule involved in angiogenesis. In this context, aerobic exercise 
may up-regulate VEGF concentration to form new vessels and increase blood flow to 
meet the added metabolic demands associated with the formation of new parenchyma. 
However, in humans, the response of VEGF to exercise following acute and chronic 
training in older adults (>60 years) is still controversial (312).  
  The aforementioned physiological changes in response to exercise of elevated 
neurotrophins, synaptogenesis, and angiogenesis to support neural proliferation result 
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in functional improvements related to cognitive function.  Evidence from cross-
sectional and randomized controlled studies shows support for the argument that 
chronic exercise leads to greater functional cerebral activation during cognitive tasks 
with fMRI (54, 164). Specifically, older adults with greater aerobic fitness showed 
significantly greater activation in the right middle frontal gyrus, superior frontal gyrus, 
superior parietal lobule and less activation in the anterior cingulate cortex while 
performing an executive function task (56). These results were essentially replicated 
with a 6-month aerobic intervention study in older adults where participants 
significantly increased activation in the right middle frontal gyrus, superior frontal 
gyrus, superior parietal lobule and less activation in the anterior cingulate cortex while 
performing a flanker task (56). The mechanisms assisting functional hyperemia are 
many and compensatory (140). However, greater activation could be the result of 
increased blood flow or flow velocity as a byproduct of exercise. Cross-sectional 
evidence has shown that individuals with greater aerobic fitness have greater cerebral 
blood flow velocity at any age (7). Alternatively, improved vascular function and 
reduced arterial stiffening could improve delivery of blood to the brain to better meet 
the metabolic demands of the cognitive task. With either explanation, a larger 
hemodynamic response could result.  
SUMMARY 
  Dementia is a significant and costly public health problem that is projected to 
worsen over the coming decades.Cognitive function is a critical factor for quality of 
life and functional ability with aging, but it begins to decline as early as the second 
decade of life (245). Therefore, exhaustive research must be performed to curb its rise 
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(94, 245). Without effective pharmaceutical interventions to halt dementia progression, 
restore lost parenchyma function, or rebuild atrophied cortex, developing evidence 
based primary prevention strategies is a critical task for the scientific community. 
 The two most common forms of dementia, Alzheimer’s disease and vascular 
dementia, appear to have a common vascular mechanism characterized by chronically 
reduced cerebral perfusion. Vessels that are normally distensible become increasingly 
stiff with aging and exposure to metabolic syndrome components and cardiovascular 
disease risk factors lead to the loss of Windkessel function and transference of 
dangerous pulsatile forces to vulnerable cerebral microvasculature. Interruptions of 
critical nutrients to metabolically demanding parenchyma may lead to oligemia and 
eventual loss of function in cortices and the white matter circuitry that connects them. 
Alterations of the cerebral white matter are considered to be early events in AD 
pathogenesis and a discrete characteristic of AD (175, 242). Although considerable 
work regarding exercise, cerebral white matter, and cognitive function has been 
performed, their integration with arterial stiffness in midlife as an incipient event 
remains unclear.  
  Physical activity, in many ways, is the closest intervention to a panacea that 
exists in the prevention and treatment of cardiovascular diseases and dementia.  
Known agitators to vascular health, adiposity, hypertension, dyslipidemia, and 
dysglycemia can all be assuaged by moving from a sedentary to a more active lifestyle.  
Arterial stiffening can also be improved with physical activity. Perhaps most 
importantly, individuals with greater aerobic fitness have greater cerebral blood flow 
velocity at any age (7). Together, these attributes identify physical activity and 
improvements to arterial stiffness as critical intervention tools for individuals in 
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midlife afflicted with cerebrovascular risk factors who are more likely to acquire 
dementia.  
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APPENDIX A: DEFINITION OF TERMS 
Adipose tissue: fat cells that primarily store energy and have endocrine like properties 
Alzheimer’s disease: a dementia subtype characterized functionally by impaired 
communication, poor judgment, memory loss, and pathophysiologically by medial 
temoral lobe degeneration, accumulated beta-amyloid plaques, and tau tangles in 
neurons. 
Arterial compliance: the absolute change in arterial volume for a given increment in 
pressure. 
Arterial distensibility: the relative change in arterial volume for a given increment in 
pressure. 
Arterial stiffness: hardening of artery walls that reduces the capability of vessels to 
buffer pulsatile blood flow ejected from the heart to deliver smooth continuous blood 
flow to end organs as the result of structural and functional changes. 
-stiffness: an arterial stiffness measure independent of the effect of distending blood 
pressure. 
Blood brain barrier: a physiological mechanism that functionally preserves a selective 
permeable neurovascular unit, comprised of vascular cells such as endothelium and 
pericytes, glial cells, and neurons. 
Cognitive function: mental processes that construct our thinking often deconstructed 
into domains consisting of attention, memory, language, problem solving, decision 
making and others that are evaluated with paper-based tests or tasks designed to 
challenge specific domains.  
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Dementia: a major neurocognitive disorder that interferes with cognitive function and 
activities of daily living.  
Fractional anisotropy: in vivo measurement of water diffusion through diffusion tensor 
imaging representing directional parallelism of water diffusion in parenchyma with 
greater values representing greater tissue integrity. 
Mean diffusivity: in vivo measurement of water diffusion through diffusion tensor 
imaging representing the magnitude of water diffusion in parenchyma reflective tissue 
with greater values representing poorer tissue integrity. 
Metabolic syndrome: a cluster of three risk factors that include abdominal obesity, 
dyslipidemia, elevated blood pressure, and hyperglycemia occurring in a single 
individual. 
Middle-age: chronological age of 40-60 years. 
Physical activity: a behavior defined by skeletal muscle movement resulting in energy 
expenditure. 
Sedentary: activities that result in a metabolic expenditure below 1.5 metabolic 
equivalent or negligible energy expenditure often involving non-upright activities. 
Vascular dementia: a dementia subtype characterized by impaired judgment or 
executive function often with co-occurrence of gait instability. Vascular dementia is 
characterized by cerebral infarcts of ischemic or vascular etiology.   
White matter hyperintensities: lesions appearing on T2-weighted MR images as bright 
spots often the result of multiple diseases but are a common feature of vascular 
cognitive impairment. These lesions are reflective of rarefication of white matter and 
are associated with axonal loss, demyelination, microvascular arteriosclerosis, and 
endothelial dysfunction. 
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White matter integrity: the structural status of white matter tracts described by 
diffusion tensor imaging metrics characterizing the diffusion of water molecules in 
vivo. 
Windkessel: the ability of the vasculature to buffer and cushion pulsatile forces that 
accompany each heartbeat and convert them into smooth continuous blood flow. 
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APPENDIX B: QUESTIONNAIRES, NEUROPSYCHOLOGICAL 
ASSESSMENTS, AND SUPPLEMENTARY INFORMATION 
 
(See supplemental documentation)
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